@NP	Human adult olfactory neural progenitors	1
@NP	axotomized rubrospinal tract	50
@NP	axonal reinnervation and locomotor recovery Ming Xiao	79
@NP	a , Kathleen M.	134
@NP	a	134
@NP	Kathleen M.	138
@NP	Klueber	150
@NP	b JianPing Zhou	158
@NP	a	174
@NP	b Zhanfang Guo	176
@NP	a Chengliang Lu	191
@NP	a Heming Wang	207
@NP	a	221
@NP	Fred J.	227
@NP	Roisenb	235
@NP	We	246
@NP	the effects	262
@NP	human adult olfactory neuroepithelial neurosphere	287
@NP	cells	345
@NP	NSFCs	352
@NP	regeneration and reinnervation of rubrospinal tract -LRB- RST -RRB- axons	362
@NP	regeneration and reinnervation	362
@NP	rubrospinal tract -LRB- RST -RRB- axons	396
@NP	locomotor recovery	430
@NP	partial cervical hemisection that completely ablated the RST	459
@NP	partial cervical hemisection	459
@NP	the RST	512
@NP	Weekly behavioral testing	521
@NP	greater functional recovery of forelimb use	554
@NP	greater functional recovery	554
@NP	forelimb use	585
@NP	the 12 weeks	605
@NP	NSFCs engraftment	624
@NP	the control rats	650
@NP	Anterograde tracing with biotinylated dextran amine -LRB- BDA -RRB-	668
@NP	Anterograde	668
@NP	dextran amine -LRB- BDA -RRB-	706
@NP	dextran amine	706
@NP	BDA	721
@NP	the presence of RST axons	736
@NP	the presence	736
@NP	RST axons	752
@NP	the white matter 4 -- 8 segments caudal	769
@NP	the white matter 4	769
@NP	8 segments	788
@NP	the grafts	809
@NP	Both immunofluorescence and immunoelectron microscopy	821
@NP	the BDA-labeled RST	884
@NP	axonal terminals	904
@NP	synaptic connections	935
@NP	motoneurons	961
@NP	the ventral horn of the distal cervical spinal cord	976
@NP	the ventral horn	976
@NP	the distal cervical spinal cord	996
@NP	Further study	1029
@NP	forelimb functional recovery	1046
@NP	NSFCs-engrafted subgroups	1078
@NP	the effects of a second dorsolateral funiculotomy	1115
@NP	the effects	1115
@NP	a second dorsolateral funiculotomy	1130
@NP	the recovery , and the injection of muscimol ,	1190
@NP	the recovery	1190
@NP	the injection of muscimol	1208
@NP	the injection	1208
@NP	muscimol	1225
@NP	RST neuronal activity	1244
@NP	These results	1278
@NP	the unique potential	1302
@NP	human olfactory neuroepithelial-derived progenitors	1326
@NP	an autologous cell source for spinal cord repair	1381
@NP	an autologous cell source	1381
@NP	spinal cord repair	1411
@NP	Introduction	1432
@NP	The failure of axons	1445
@NP	The failure	1445
@NP	axons	1460
@NP	the adult central nervous system	1483
@NP	CNS	1517
@NP	the intrinsic regenerative capacity	1545
@NP	injured neurons as well as a nonpermissive environment	1584
@NP	injured neurons	1584
@NP	a nonpermissive environment	1611
@NP	Beattie	1640
@NP	et al. , 1997 ; Geller and Fawcett , 2002	1648
@NP	et al.	1648
@NP	1997 ; Geller and Fawcett	1656
@NP	1997	1656
@NP	Geller and Fawcett	1662
@NP	2002	1682
@NP	the past decade	1692
@NP	cellular replacement therapies	1709
@NP	exciting new therapeutic options	1752
@NP	regeneration	1796
@NP	several neurodegenerative or neurotrauma models	1812
@NP	these cellular grafts	2284
@NP	injured axonal regeneration and animals ' functional recovery	2320
@NP	injured axonal regeneration	2320
@NP	animals ' functional recovery	2352
@NP	animals '	2352
@NP	further research	2382
@NP	they	2416
@NP	patients	2442
@NP	SCI -LRB- Kwon and Tetzlaff , 2001 -RRB-	2456
@NP	SCI	2456
@NP	Kwon and Tetzlaff	2461
@NP	2001	2480
@NP	date	2493
@NP	lack of suitable donor sites or ethical and technical problems	2499
@NP	lack	2499
@NP	suitable donor sites or ethical and technical problems	2507
@NP	suitable donor sites	2507
@NP	ethical and technical problems	2531
@NP	a major limitation	2572
@NP	cellular replacement therapies	2594
@NP	clinical treatments -LRB- Mata et al. , 2002 ; Kawaguchi et al. , 2004 -RRB-	2637
@NP	clinical treatments	2637
@NP	Mata	2658
@NP	et al. , 2002 ; Kawaguchi et al. , 2004	2663
@NP	et al.	2663
@NP	2002 ; Kawaguchi et al.	2671
@NP	2002	2671
@NP	Kawaguchi et al.	2677
@NP	Kawaguchi	2677
@NP	et al.	2687
@NP	2004	2695
@NP	we and others	2713
@NP	a more readily accessible source of human cells	2747
@NP	a more readily accessible source	2747
@NP	human cells	2783
@NP	the potential for autologous transplantation	2812
@NP	the potential	2812
@NP	autologous transplantation	2830
@NP	Feron et al. , 1998 ; Roisen et al. , 2001	2869
@NP	Feron	2869
@NP	et al. , 1998 ; Roisen et al. , 2001	2875
@NP	et al. , 1998	2875
@NP	et al.	2875
@NP	1998	2883
@NP	Roisen et al. , 2001	2889
@NP	Roisen	2889
@NP	et al. , 2001	2896
@NP	et al.	2896
@NP	2001	2904
@NP	The olfactory neuroepithelium -LRB- ONe -RRB-	2911
@NP	The olfactory neuroepithelium	2911
@NP	ONe	2942
@NP	other regions of the CNS	2969
@NP	other regions	2969
@NP	the CNS	2986
@NP	it	2995
@NP	damaged neurons and glia	3038
@NP	life -LRB- Calof and Chikaraishi , 1989 ; Sosnowski et al. , 1995 -RRB-	3074
@NP	life	3074
@NP	Calof and Chikaraishi	3080
@NP	Calof	3080
@NP	Chikaraishi	3090
@NP	1989 ; Sosnowski et al. , 1995	3103
@NP	1989	3103
@NP	Sosnowski et al. , 1995	3109
@NP	Sosnowski	3109
@NP	et al. , 1995	3119
@NP	et al.	3119
@NP	1995	3127
@NP	Adult human ONe	3134
@NP	a unique source	3162
@NP	adult neural progenitors	3181
@NP	an individual	3234
@NP	invasive surgery	3256
@NP	Calof and Chikaraishi	3274
@NP	Calof	3274
@NP	Chikaraishi	3284
@NP	1989 ; Winstead et al. , 2005	3297
@NP	1989	3297
@NP	Winstead et al. , 2005	3303
@NP	Winstead	3303
@NP	et al. , 2005	3312
@NP	et al.	3312
@NP	2005	3320
@NP	the last several years	3330
@NP	we	3354
@NP	the procedures	3367
@NP	isolation and culture	3386
@NP	adult human ONe-derived neurosphere-forming cells -LRB- NSFCs -RRB-	3411
@NP	adult human ONe-derived neurosphere-forming cells	3411
@NP	NSFCs	3462
@NP	cadavers -LRB- Roisen et al. , 2001 -RRB-	3474
@NP	cadavers	3474
@NP	Roisen	3484
@NP	et al. , 2001	3491
@NP	et al.	3491
@NP	2001	3499
@NP	patients undergoing nasal sinus surgery -LRB- Winstead et al. , 2005 -RRB-	3508
@NP	patients	3508
@NP	nasal sinus surgery -LRB- Winstead et al. , 2005 -RRB-	3528
@NP	nasal sinus surgery	3528
@NP	Winstead	3549
@NP	et al. , 2005	3558
@NP	et al.	3558
@NP	2005	3566
@NP	Serial in vitro studies	3573
@NP	Serial	3573
@NP	NSFCs	3620
@NP	characteristics	3631
@NP	neural progenitors	3650
@NP	a remarkable level of proliferation and viability	3683
@NP	a remarkable level	3683
@NP	proliferation and viability	3705
@NP	Zhang et al. , 2004 ; Marshall et al. , 2005 ; Othman et al. , 2005	3734
@NP	Zhang	3734
@NP	et al. , 2004 ; Marshall et al. , 2005 ; Othman et al. , 2005	3740
@NP	et al. , 2004	3740
@NP	et al.	3740
@NP	2004	3748
@NP	Marshall et al. , 2005	3754
@NP	Marshall	3754
@NP	et al. , 2005	3763
@NP	et al.	3763
@NP	2005	3771
@NP	Othman et al. , 2005	3777
@NP	Othman	3777
@NP	et al. , 2005	3784
@NP	et al.	3784
@NP	2005	3792
@NP	a stable potential	3802
@NP	neuronal or glial lineage restriction	3844
@NP	environmental signals in culture	3895
@NP	environmental signals	3895
@NP	culture	3920
@NP	Zhang	3929
@NP	et al. , 2005 , 2006a , b	3935
@NP	et al.	3935
@NP	2005	3943
@NP	2006a	3949
@NP	b	3955
@NP	NSFCs lines	3972
@NP	nerve growth factor	3992
@NP	brainderived neurotrophic factor -LRB- BDNF -RRB-	4013
@NP	brainderived neurotrophic factor	4013
@NP	BDNF	4047
@NP	passage	4067
@NP	number , donor age or donor sex -LRB- Xiao et al. , 2005 -RRB-	4075
@NP	number , donor age or donor sex	4075
@NP	Xiao	4107
@NP	et al. , 2005	4112
@NP	et al.	4112
@NP	2005	4120
@NP	One-week delayed transplantation	4127
@NP	GFP-labeled NSFCs into a partial cervical hemisection	4163
@NP	GFP-labeled NSFCs	4163
@NP	a partial cervical hemisection	4186
@NP	PCHX	4218
@NP	rat model	4224
@NP	NSFCs	4266
@NP	host spinal cord	4308
@NP	rescue	4329
@NP	rubrospinal tract -LRB- RST -RRB- neurons from retrograde atrophy	4347
@NP	rubrospinal tract -LRB- RST -RRB- neurons	4347
@NP	RST	4366
@NP	retrograde atrophy	4384
@NP	RST axonal regeneration	4422
@NP	functional recovery -LRB- Xiao et al. , 2005 -RRB-	4460
@NP	functional recovery	4460
@NP	Xiao	4481
@NP	et al. , 2005	4486
@NP	et al.	4486
@NP	2005	4494
@NP	the potential	4530
@NP	the ONe progenitors	4554
@NP	future autologous cell replacement strategies	4578
@NP	the SCI	4627
@NP	the present study	4636
@NP	the effects of NSFCs	4687
@NP	the effects	4687
@NP	NSFCs	4702
@NP	reinnervation of axotomized RST axons following the acute PCHX	4711
@NP	reinnervation	4711
@NP	axotomized RST axons following the acute PCHX	4728
@NP	axotomized RST axons	4728
@NP	the acute PCHX	4759
@NP	forelimb functional recovery	4801
@NP	irreversible and reversible lesions of regenerated RST	4833
@NP	irreversible and reversible lesions	4833
@NP	regenerated RST	4872
@NP	Materials and methods	4890
@NP	Materials	4890
@NP	methods	4904
@NP	Preparation	4912
@NP	GFP-labeled NSFCs for engraftment	4927
@NP	GFP-labeled NSFCs	4927
@NP	engraftment	4949
@NP	The culture of GFP-labeled NSFCs for engraftment	4961
@NP	The culture	4961
@NP	GFP-labeled NSFCs for engraftment	4976
@NP	GFP-labeled NSFCs	4976
@NP	engraftment	4998
@NP	Xiao et al. , 2005	5041
@NP	Xiao	5041
@NP	et al.	5046
@NP	2005	5054
@NP	brief	5064
@NP	two patient specific ONe-derived NSFCs lines	5071
@NP	two patient	5071
@NP	specific ONe-derived NSFCs lines	5083
@NP	green fluorescent protein -LRB- GFP -RRB-	5160
@NP	green fluorescent protein	5160
@NP	GFP	5187
@NP	the LERS -- EGFP vector -LRB- Kinsella and Nolan , 1996 -RRB-	5198
@NP	the LERS	5198
@NP	EGFP vector -LRB- Kinsella and Nolan , 1996 -RRB-	5208
@NP	EGFP vector	5208
@NP	Kinsella and Nolan , 1996	5221
@NP	Kinsella	5221
@NP	Nolan , 1996	5234
@NP	Nolan	5234
@NP	1996	5241
@NP	transfection	5254
@NP	the GFP	5268
@NP	> 60 % of the cells	5300
@NP	>	5300
@NP	the cells	5308
@NP	These cells	5319
@NP	up to 40 passages	5349
@NP	representative passages	5371
@NP	liquid nitrogen for transplantation	5410
@NP	liquid nitrogen	5410
@NP	transplantation	5430
@NP	1 week prior to engraftment	5450
@NP	1 week	5450
@NP	engraftment	5466
@NP	GFP-labeled NSFCs	5479
@NP	frozen stock	5516
@NP	Minimal Essential Medium -LRB- MEM -RRB- +10 %	5561
@NP	Minimal Essential Medium	5561
@NP	MEM	5587
@NP	+10 %	5592
@NP	fetal bovine serum	5597
@NP	FBS	5617
@NP	they	5635
@NP	FBS 10 % , 5 % to 2.5 % every 2 days	5657
@NP	FBS 10 %	5657
@NP	FBS	5657
@NP	5 % to 2.5 % every	5666
@NP	2 days	5683
@NP	MEM	5719
@NP	+2.5 % FBS	5722
@NP	+2.5 %	5722
@NP	FBS	5728
@NP	15 to 30 min prior to injection	5736
@NP	15 to 30 min	5736
@NP	injection	5758
@NP	NSFCs	5769
@NP	the culture surface	5794
@NP	lowspeed centrifugation	5827
@NP	MEM +2.5 % FBS	5877
@NP	MEM	5877
@NP	+2.5 % FBS	5880
@NP	Matrigel ® matrix -LRB- 1:1 , BD Biosciences -RRB- at a concentration of 2 ×	5894
@NP	Matrigel ® matrix -LRB- 1:1 , BD Biosciences -RRB-	5894
@NP	Matrigel ® matrix	5894
@NP	1:1	5912
@NP	BD Biosciences	5917
@NP	a concentration of 2 ×	5936
@NP	a concentration	5936
@NP	2 ×	5955
@NP	104 cells/μl	5957
@NP	4 °C	5988
@NP	The remaining cells	5994
@NP	3	6045
@NP	4 days for immunocytochemical characterization and RT	6047
@NP	4 days	6047
@NP	immunocytochemical characterization and RT	6058
@NP	PCR and ELISA	6101
@NP	cell lysates for BDNF as previously described -LRB- Xiao et al. , 2005 -RRB-	6118
@NP	cell lysates	6118
@NP	BDNF as previously described -LRB- Xiao et al. , 2005 -RRB-	6135
@NP	BDNF	6135
@NP	Xiao	6165
@NP	et al. , 2005	6170
@NP	et al.	6170
@NP	2005	6178
@NP	Experimental paradigm Fifty-two female adult Sprague Dawley rats	6185
@NP	Experimental paradigm	6185
@NP	Fifty-two female adult Sprague Dawley rats	6207
@NP	experimental group -LRB- n = 48 -RRB- and normal control group -LRB- n = 4 -RRB-	6268
@NP	experimental group	6268
@NP	n	6288
@NP	48	6290
@NP	normal control group	6298
@NP	n	6320
@NP	4	6322
@NP	an introductory period of 2 weeks	6332
@NP	an introductory period	6332
@NP	2 weeks	6358
@NP	the rats	6367
@NP	their forelimb posture	6394
@NP	the data	6421
@NP	the baseline data	6449
@NP	surgery	6476
@NP	Normal control rats	6485
@NP	dextran amine	6527
@NP	BDA	6542
@NP	injection	6547
@NP	baseline data	6570
@NP	anterograde tracing from the RN	6588
@NP	anterograde	6588
@NP	the RN	6613
@NP	All rats in the experimental group	6621
@NP	All rats	6621
@NP	the experimental group	6633
@NP	a PCHX	6665
@NP	the right mid-cervical	6675
@NP	C3	6699
@NP	cord	6705
@NP	either a transplant	6714
@NP	GFP-labeled NSFCs suspended in Matrigel ® matrix	6737
@NP	GFP-labeled NSFCs	6737
@NP	Matrigel ® matrix	6768
@NP	n	6786
@NP	30	6788
@NP	Matrigel ® matrix alone -LRB- n = 18	6795
@NP	Matrigel	6795
@NP	® matrix alone -LRB- n = 18	6803
@NP	® matrix alone	6803
@NP	n = 18	6819
@NP	n	6819
@NP	18	6821
@NP	These rats	6826
@NP	12 weeks for forelimb posture and spontaneous vertical exploration	6862
@NP	12 weeks	6862
@NP	forelimb posture and spontaneous vertical exploration	6875
@NP	forelimb posture	6875
@NP	spontaneous vertical exploration	6896
@NP	12 weeks	6933
@NP	the animals	6960
@NP	three subgroups	6999
@NP	Animals in the first subgroup -LRB- n = 24 -RRB-	7016
@NP	Animals	7016
@NP	the first subgroup -LRB- n = 24 -RRB-	7027
@NP	the first subgroup	7027
@NP	n	7047
@NP	24	7049
@NP	a BDA injection	7062
@NP	the left RN	7083
@NP	an additional 2 weeks	7108
@NP	immunohistochemistry and immunoelectron microscopic analysis	7156
@NP	Animals in the second subgroup -LRB- n = 12 -RRB-	7218
@NP	Animals	7218
@NP	the second subgroup -LRB- n = 12 -RRB-	7229
@NP	the second subgroup	7229
@NP	n	7250
@NP	12	7252
@NP	a dorsolateral funiculotomy -LRB- DLF -RRB-	7265
@NP	a dorsolateral funiculotomy	7265
@NP	DLF	7294
@NP	C2	7302
@NP	the right RST	7314
@NP	behavioral testing weekly for 4 additional weeks	7340
@NP	behavioral testing weekly	7340
@NP	4 additional weeks	7370
@NP	sacrifice	7396
@NP	Animals in the third subgroup -LRB- n = 12 -RRB-	7407
@NP	Animals	7407
@NP	the third subgroup -LRB- n = 12 -RRB-	7418
@NP	the third subgroup	7418
@NP	n	7438
@NP	12	7440
@NP	an injection of muscimol or saline	7453
@NP	an injection	7453
@NP	muscimol or saline	7469
@NP	the left RN	7493
@NP	RN neuronal function	7525
@NP	posture and use	7556
@NP	10 -- 12 h after injection , and 48 h after injection after recovery	7594
@NP	10 -- 12 h after injection	7594
@NP	10	7594
@NP	12 h after injection	7597
@NP	12 h	7597
@NP	injection	7608
@NP	48 h after injection after recovery	7623
@NP	48 h	7623
@NP	injection after recovery	7634
@NP	injection	7634
@NP	recovery	7650
@NP	2 days later	7660
@NP	these animals	7674
@NP	an additional injection of muscimol or saline	7697
@NP	an additional injection	7697
@NP	muscimol or saline	7724
@NP	histological study	7772
@NP	All animals in the experimental groups	7792
@NP	All animals	7792
@NP	the experimental groups	7807
@NP	an identical protocol	7840
@NP	prevention of inflammation	7866
@NP	prevention	7866
@NP	inflammation	7880
@NP	penicillin and immunosuppression	7898
@NP	cyclosporine as previously described -LRB- Xiao et al. , 2005 -RRB-	7936
@NP	cyclosporine	7936
@NP	Xiao	7974
@NP	et al. , 2005	7979
@NP	et al.	7979
@NP	2005	7987
@NP	All the above procedures	7994
@NP	the Animal Care and Use Committee of Nanjing Medical University	8036
@NP	the Animal Care and Use Committee	8036
@NP	Nanjing Medical University	8073
@NP	accord	8112
@NP	the National Institutes of Health guidelines	8124
@NP	Health	8151
@NP	the care and use of laboratory animals	8173
@NP	the care and use	8173
@NP	laboratory animals	8193
@NP	Surgical procedures	8213
@NP	The unilateral C3 -- 4 PCHX was performed as previously described	8233
@NP	The unilateral C3	8233
@NP	4 PCHX	8251
@NP	Liu et al. , 1999 , Xiao et al. , 2005	8297
@NP	Liu	8297
@NP	et al. , 1999 , Xiao et al. , 2005	8301
@NP	et al.	8301
@NP	1999	8309
@NP	Xiao et al.	8315
@NP	Xiao	8315
@NP	et al.	8320
@NP	2005	8328
@NP	rats	8344
@NP	an intraperitoneal injection of ketamine , 100 mg/kg , and xylazine , 10 mg/kg	8377
@NP	an intraperitoneal injection	8377
@NP	ketamine , 100 mg/kg , and xylazine , 10 mg/kg	8409
@NP	ketamine	8409
@NP	100 mg/kg	8419
@NP	xylazine , 10 mg/kg	8434
@NP	xylazine	8434
@NP	10 mg/kg	8444
@NP	The spinal cord	8454
@NP	dorsal laminectomy of the C3 and C4 vertebrae	8485
@NP	dorsal laminectomy	8485
@NP	the C3 and C4 vertebrae	8507
@NP	a cavity	8536
@NP	1.5 mm	8545
@NP	microscissors and gentle aspiration	8573
@NP	microscissors	8573
@NP	gentle aspiration	8591
@NP	the right lateral funiculus of the spinal cord	8612
@NP	the right lateral funiculus	8612
@NP	the spinal cord	8643
@NP	The lesion	8660
@NP	the axons of the RST in the right dorsolateral and lateral funiculi , partly	8690
@NP	the axons	8690
@NP	the RST in the right dorsolateral and lateral funiculi , partly	8703
@NP	the RST in the right dorsolateral	8703
@NP	the RST	8703
@NP	the right dorsolateral	8714
@NP	lateral funiculi , partly	8741
@NP	lateral funiculi	8741
@NP	the right dorsal and ventral columns and gray matter	8774
@NP	the right dorsal	8774
@NP	ventral columns and gray matter	8795
@NP	ventral columns	8795
@NP	gray matter	8815
@NP	the left dorsal column	8832
@NP	A piece of gel foam	8872
@NP	A piece	8872
@NP	gel foam	8883
@NP	the cavity	8906
@NP	the bleeding	8925
@NP	5 min	8956
@NP	GFP-labeled NSFCs , 8 -- 10 μl -LRB- 2 × 104 cells/μl -RRB- ,	8963
@NP	GFP-labeled NSFCs	8963
@NP	8 -- 10 μl -LRB- 2 × 104 cells/μl -RRB-	8982
@NP	8	8982
@NP	10 μl -LRB- 2 × 104 cells/μl -RRB-	8984
@NP	2 × 104 cells/μl	8991
@NP	2 ×	8991
@NP	104 cells/μl	8993
@NP	MEM	9021
@NP	+2.5 % FBS	9024
@NP	+2.5 %	9024
@NP	FBS	9030
@NP	Matrigel ® matrix -LRB- 1:1 -RRB-	9038
@NP	Matrigel ® matrix	9038
@NP	1:1	9056
@NP	MEM +2.5 % FBS and Matrigel ® matrix alone was drawn into a 25 μl	9064
@NP	MEM	9064
@NP	+2.5 % FBS and Matrigel ® matrix	9067
@NP	+2.5 % FBS	9067
@NP	Matrigel ® matrix	9081
@NP	a 25 μl	9119
@NP	Hamilton syringe attached to a glass pipette	9127
@NP	Hamilton syringe	9127
@NP	a glass pipette	9156
@NP	50 μm tip diameter	9173
@NP	The syringe	9194
@NP	1	9231
@NP	2 min	9233
@NP	the Matrigel ® matrix	9248
@NP	the gel	9298
@NP	the lesion site	9331
@NP	The dura mater and muscles	9348
@NP	The dura mater	9348
@NP	muscles	9367
@NP	sutures	9392
@NP	the skin	9406
@NP	wound clips	9431
@NP	DLF	9448
@NP	animals	9453
@NP	a second laminectomy	9496
@NP	the level of C2	9520
@NP	the level	9520
@NP	C2	9533
@NP	removal	9549
@NP	the right dorsolateral quadrant using the same procedure as described above	9560
@NP	the right dorsolateral quadrant	9560
@NP	the same procedure	9598
@NP	muscimol or BDA injection	9641
@NP	animals	9668
@NP	a stereotaxic apparatus	9731
@NP	the coordinates described previously -LRB- Mori et al. , 1997 -RRB-	9769
@NP	the	9769
@NP	Mori et al. , 1997	9807
@NP	Mori	9807
@NP	et al.	9812
@NP	1997	9820
@NP	the magnocellular portion of the left RN	9827
@NP	the magnocellular portion	9827
@NP	the left RN	9856
@NP	the injection site	9886
@NP	Three-tenths	9906
@NP	a microliter of 0.1 % muscimol -LRB- Sigma , Chemical , CO -RRB-	9922
@NP	a microliter	9922
@NP	0.1 % muscimol -LRB- Sigma , Chemical , CO -RRB-	9938
@NP	0.1 % muscimol	9938
@NP	Sigma	9953
@NP	Chemical	9960
@NP	CO	9970
@NP	10 % BDA -LRB- Molecular Probes , Leiden , The Netherlands -RRB-	9977
@NP	10 % BDA	9977
@NP	Molecular Probes	9986
@NP	Leiden	10004
@NP	The Netherlands	10012
@NP	0.9 % saline solution -LRB- or saline alone -RRB-	10032
@NP	0.9 % saline solution	10032
@NP	saline alone	10057
@NP	saline	10057
@NP	5 -- 6 min in six 50-nl pulses	10097
@NP	5	10097
@NP	6 min in six 50-nl pulses	10099
@NP	6 min	10099
@NP	six 50-nl pulses	10108
@NP	a micropipette	10133
@NP	tip diameter	10149
@NP	30 -- 40 μm	10162
@NP	30	10162
@NP	40 μm	10165
@NP	a 1-μl Hamilton syringe	10184
@NP	The needle	10209
@NP	place for an additional 20 min	10232
@NP	place	10232
@NP	an additional 20 min	10242
@NP	2 -- 3 min	10293
@NP	2	10293
@NP	3 min	10295
@NP	posture and behavioral testing Forelimb posture	10311
@NP	posture	10311
@NP	behavioral testing Forelimb posture	10323
@NP	different times	10375
@NP	the operation to study reinnervation of the forelimb	10397
@NP	reinnervation of the forelimb	10420
@NP	reinnervation	10420
@NP	the forelimb	10437
@NP	Flexion of the forepaw	10451
@NP	Flexion	10451
@NP	the forepaw	10462
@NP	the animals	10492
@NP	anesthesia	10519
@NP	An initial deficit in this respect	10555
@NP	An initial deficit	10555
@NP	this respect	10577
@NP	damage	10609
@NP	the RST following the PCHX	10619
@NP	the RST	10619
@NP	the PCHX	10637
@NP	Forelimb use during vertical exploration	10647
@NP	Forelimb use	10647
@NP	vertical exploration	10667
@NP	a highly sensitive test for asymmetries of limb function	10691
@NP	a highly sensitive test	10691
@NP	asymmetries of limb function	10719
@NP	asymmetries	10719
@NP	limb function	10734
@NP	repeated testing	10753
@NP	the asymmetry score -LRB- Liu et al. , 1999 ; Jin et al. , 2002 -RRB-	10789
@NP	the asymmetry score	10789
@NP	Liu	10810
@NP	et al. , 1999 ; Jin et al. , 2002	10814
@NP	et al.	10814
@NP	1999 ; Jin et al.	10822
@NP	1999	10822
@NP	Jin et al.	10828
@NP	Jin	10828
@NP	et al.	10832
@NP	2002	10840
@NP	The rats	10847
@NP	one	10867
@NP	preoperative test	10871
@NP	engraftment	10920
@NP	All behavioral performance tests	10933
@NP	a double-blind study	10984
@NP	The procedure for this behavioral test	11006
@NP	The procedure	11006
@NP	this behavioral test	11024
@NP	Xiao et al. , 2005	11071
@NP	Xiao	11071
@NP	et al.	11076
@NP	2005	11084
@NP	brief	11094
@NP	rats	11101
@NP	a clear glass cylinder 20 cm in diameter and 30 cm high for 5 min	11121
@NP	a clear glass cylinder 20 cm in diameter	11121
@NP	a clear glass cylinder 20 cm	11121
@NP	diameter	11153
@NP	30 cm high for 5 min	11166
@NP	30 cm	11166
@NP	5 min	11181
@NP	independent use of the left forelimb , right forelimb , or both	11202
@NP	independent use	11202
@NP	the left forelimb , right forelimb , or both	11221
@NP	the left forelimb	11221
@NP	right forelimb	11240
@NP	both	11259
@NP	the wall of the cylinder	11279
@NP	the wall	11279
@NP	the cylinder	11291
@NP	vertical posturing	11311
@NP	Each behavior	11331
@NP	terms of percent forelimb use of the left , right or both relative	11362
@NP	terms	11362
@NP	percent forelimb use of the left , right or both relative	11371
@NP	percent forelimb use	11371
@NP	the left , right or both relative	11395
@NP	the left	11395
@NP	right	11405
@NP	both relative	11414
@NP	the total	11431
@NP	Tissue preparation Animals	11442
@NP	an overdose	11499
@NP	ketamine and xylazine	11514
@NP	the heart with 200 ml of 0.01 M PBS , pH 7.4	11554
@NP	the heart	11554
@NP	200 ml of 0.01 M PBS , pH 7.4	11569
@NP	200 ml	11569
@NP	0.01 M PBS , pH 7.4	11579
@NP	0.01 M PBS	11579
@NP	pH 7.4	11591
@NP	500 ml of an ice-cold , freshly prepared solution of 4 % formaldehyde	11611
@NP	500 ml	11611
@NP	an ice-cold , freshly prepared solution of 4 % formaldehyde	11621
@NP	an ice-cold , freshly prepared solution	11621
@NP	4 % formaldehyde	11663
@NP	immunofluorescent histochemistry	11692
@NP	0.5 % glutaraldehyde	11734
@NP	immunoelectron microscopy	11759
@NP	0.1 M PB -LRB- pH 7.4 -RRB-	11789
@NP	0.1 M PB	11789
@NP	pH 7.4	11799
@NP	The midbrain and the whole spinal cord , including the dorsal roots	11808
@NP	The midbrain	11808
@NP	the whole spinal cord	11825
@NP	the dorsal roots	11858
@NP	the same fixative at 4 °C overnight	11910
@NP	the same fixative at 4 °C	11910
@NP	the same fixative	11910
@NP	4 °C	11931
@NP	cytoprotection in PB	11958
@NP	cytoprotection	11958
@NP	PB	11976
@NP	30 % sucrose	11990
@NP	1	12006
@NP	2 days at 4 °C	12008
@NP	2 days	12008
@NP	4 °C	12018
@NP	Spinal cord and midbrain	12024
@NP	Spinal cord	12024
@NP	midbrain	12040
@NP	OCT compound	12066
@NP	20 μm	12099
@NP	a cryostat	12108
@NP	gelatin-coated slides	12134
@NP	immunoelectron microscopic processing	12161
@NP	the specimens	12200
@NP	the coronal plane with a vibratome -LRB- Leica , Germany -RRB-	12226
@NP	the coronal plane	12226
@NP	a vibratome -LRB- Leica , Germany -RRB-	12249
@NP	a vibratome	12249
@NP	Leica	12262
@NP	Germany	12269
@NP	sections with a thickness of 50 μm	12283
@NP	sections	12283
@NP	a thickness of 50 μm	12297
@NP	a thickness	12297
@NP	50 μm	12312
@NP	0.1 M PB -LRB- pH 7.4 -RRB-	12335
@NP	0.1 M PB	12335
@NP	pH 7.4	12345
@NP	Histology	12354
@NP	immunocytochemistry Toluidine blue and immunocytochemical staining procedures	12368
@NP	immunocytochemistry Toluidine	12368
@NP	blue and immunocytochemical staining procedures	12398
@NP	Xiao et al. , 2005	12476
@NP	Xiao	12476
@NP	et al.	12481
@NP	2005	12489
@NP	immunocytochemistry	12500
@NP	sections	12530
@NP	immunostained overnight	12544
@NP	4 °C	12571
@NP	a rabbit	12581
@NP	polyclonal anti-GFP antibody	12590
@NP	1:100 ; Chemicon , Temecula , CA , USA	12620
@NP	1:100	12620
@NP	Chemicon , Temecula , CA , USA	12627
@NP	mouse monoclonal anti-glial fibrillary acidic protein	12660
@NP	GFAP	12715
@NP	antibody -LRB- 1:300 ; Chemicon , Temecula , CA , USA -RRB-	12721
@NP	antibody	12721
@NP	1:300 ; Chemicon , Temecula , CA , USA	12731
@NP	1:300	12731
@NP	Chemicon , Temecula , CA , USA	12738
@NP	mouse monoclonal anti-microtubule associated protein -LRB- MAP-2 -RRB-	12768
@NP	mouse	12768
@NP	monoclonal anti-microtubule associated protein -LRB- MAP-2 -RRB-	12774
@NP	monoclonal anti-microtubule associated protein	12774
@NP	MAP-2	12822
@NP	antibody -LRB- 1:200 ; Sigma , St.	12829
@NP	antibody	12829
@NP	1:200 ; Sigma , St.	12839
@NP	1:200	12839
@NP	Sigma , St.	12846
@NP	Louis , MO , USA -RRB- ,	12857
@NP	Louis	12857
@NP	MO	12864
@NP	USA	12868
@NP	mouse	12874
@NP	monoclonal anti-BDNF antibody -LRB- 1:200 ; Chemicon , Temecula , CA , USA -RRB-	12880
@NP	monoclonal anti-BDNF antibody	12880
@NP	1:200 ; Chemicon , Temecula , CA , USA	12911
@NP	1:200	12911
@NP	Chemicon , Temecula , CA , USA	12918
@NP	mouse	12951
@NP	monoclonal anti-ED-1 antibody -LRB- 1:400 ; Chemicon , Temecula , CA , USA -RRB-	12957
@NP	monoclonal anti-ED-1 antibody	12957
@NP	1:400 ; Chemicon , Temecula , CA , USA	12988
@NP	1:400	12988
@NP	Chemicon , Temecula , CA , USA	12995
@NP	secondary antibodies	13054
@NP	Texas Red-conjugate goat anti-mouse IgG and FITC-conjugate goat anti-rabbit IgG	13076
@NP	Texas Red-conjugate goat	13076
@NP	anti-mouse IgG and FITC-conjugate goat	13101
@NP	anti-rabbit IgG	13140
@NP	1:100	13164
@NP	Texas Red , Molecular Probes , Eugene , OR	13171
@NP	Texas Red	13171
@NP	Molecular Probes	13182
@NP	Eugene	13200
@NP	OR	13208
@NP	USA ; FITC , Cappel , West Chester , PA , USA	13212
@NP	USA	13212
@NP	FITC , Cappel , West Chester , PA , USA	13217
@NP	FITC	13217
@NP	Cappel	13223
@NP	West Chester	13231
@NP	PA	13245
@NP	USA	13249
@NP	GFAP and ED-1 staining	13272
@NP	sections	13296
@NP	a	13336
@NP	goat	13351
@NP	anti rabbit IgG -LRB- 1:150 , Vector laboratories , Burlingame , CA , USA -RRB-	13356
@NP	anti rabbit IgG	13356
@NP	1:150 , Vector laboratories , Burlingame , CA , USA	13373
@NP	1:150	13373
@NP	Vector laboratories	13380
@NP	Burlingame	13401
@NP	CA	13413
@NP	USA	13417
@NP	avidin -- biotin	13426
@NP	avidin	13426
@NP	biotin	13434
@NP	peroxidase complex	13441
@NP	1:150 , Vector laboratories , Burlingame , CA , USA	13461
@NP	1:150	13461
@NP	Vector laboratories	13468
@NP	Burlingame	13489
@NP	CA	13501
@NP	USA	13505
@NP	1 h	13514
@NP	room temperature	13521
@NP	The immunoreactive product	13539
@NP	hydrogen peroxidase and diaminobenzidine	13587
@NP	chromogen	13631
@NP	Omission of primary or secondary antibodies	13642
@NP	Omission	13642
@NP	primary or secondary antibodies	13654
@NP	the specificity of the reaction	13694
@NP	the specificity	13694
@NP	the reaction	13713
@NP	BDA immunofluorescence	13731
@NP	sections of spinal cord or midbrain from the sixteen BDA tracing rats	13755
@NP	sections of spinal cord	13755
@NP	sections	13755
@NP	spinal cord	13767
@NP	midbrain from the sixteen BDA tracing rats	13782
@NP	the sixteen BDA tracing	13796
@NP	the sixteen BDA	13796
@NP	biotin	13843
@NP	FITC -LRB- Sigma , St.	13850
@NP	FITC	13850
@NP	Sigma	13856
@NP	St.	13863
@NP	Louis , MO , USA -RRB-	13867
@NP	Louis	13867
@NP	MO	13874
@NP	USA	13878
@NP	previous procedures -LRB- Liu et al. , 1999 ; Xiao et al. , 2005 -RRB-	13889
@NP	previous procedures	13889
@NP	Liu	13910
@NP	et al. , 1999 ; Xiao et al. , 2005	13914
@NP	et al.	13914
@NP	1999 ; Xiao et al.	13922
@NP	1999	13922
@NP	Xiao et al.	13928
@NP	Xiao	13928
@NP	et al.	13933
@NP	2005	13941
@NP	biotin -- FITC/synapsin I	13952
@NP	biotin	13952
@NP	FITC/synapsin I	13960
@NP	FITC/synapsin	13960
@NP	I	13974
@NP	spinal cord sections	13977
@NP	4 °C with goat anti-biotin FITC conjugate antibody -LRB- 1:50 -RRB-	14026
@NP	4 °C	14026
@NP	goat anti-biotin FITC conjugate antibody -LRB- 1:50 -RRB-	14036
@NP	goat anti-biotin FITC conjugate antibody	14036
@NP	goat	14036
@NP	anti-biotin FITC conjugate antibody	14041
@NP	1:50	14078
@NP	three times	14092
@NP	30 min	14108
@NP	PBS	14120
@NP	4 °C with rabbit	14148
@NP	4 °C	14148
@NP	rabbit	14158
@NP	I antibody -LRB- 1:100 ; Sigma , St.	14190
@NP	I	14190
@NP	antibody -LRB- 1:100 ; Sigma , St.	14192
@NP	antibody	14192
@NP	1:100 ; Sigma , St.	14202
@NP	1:100	14202
@NP	Sigma , St.	14209
@NP	Louis , MO , USA -RRB-	14220
@NP	Louis	14220
@NP	MO	14227
@NP	USA	14231
@NP	three times	14243
@NP	10 min each	14259
@NP	10 min	14259
@NP	each	14266
@NP	PBS	14276
@NP	room temperature	14297
@NP	the secondary antibodies Texas Red-conjugate donkey anti-rabbit IgG	14319
@NP	the secondary antibodies Texas Red-conjugate	14319
@NP	donkey anti-rabbit IgG	14364
@NP	1:150	14388
@NP	Molecular Probes , Eugene , OR , USA	14395
@NP	Molecular Probes	14395
@NP	Eugene	14413
@NP	OR	14421
@NP	USA	14425
@NP	1 h.	14434
@NP	Sections	14439
@NP	Primary or secondary antibody omission	14473
@NP	Primary	14473
@NP	secondary antibody omission	14484
@NP	the specificity of each reaction	14534
@NP	the specificity	14534
@NP	each reaction	14553
@NP	BDA immunoelectron microscopic processing	14572
@NP	sections of C6 -- 7 segments	14615
@NP	sections	14615
@NP	C6 -- 7 segments	14627
@NP	C6	14627
@NP	7 segments	14630
@NP	other eight BDA	14646
@NP	eight	14652
@NP	rats	14670
@NP	an ABC elite kit -LRB- Vector -RRB-	14693
@NP	an ABC elite kit	14693
@NP	Vector	14711
@NP	nickelintensified diaminobenzidine	14739
@NP	Kuchler	14775
@NP	et al. , 2002	14783
@NP	et al.	14783
@NP	2002	14791
@NP	freefloating sections	14807
@NP	three times , 30 min each ,	14841
@NP	three times	14841
@NP	30 min each	14854
@NP	30 min	14854
@NP	each	14861
@NP	TBST -LRB- 50 mM Tris-buffered saline , pH 7.4 -RRB-	14870
@NP	TBST	14870
@NP	50 mM Tris-buffered saline , pH 7.4	14876
@NP	50 mM	14876
@NP	Tris-buffered saline	14882
@NP	pH 7.4	14904
@NP	overnight	14928
@NP	an avidin -- biotin -- peroxidase complex	14943
@NP	an avidin	14943
@NP	biotin	14953
@NP	peroxidase complex	14960
@NP	room temperature	14982
@NP	ABC	15000
@NP	Vectastain Elite ABC Kit , Vector Laboratories , USA	15005
@NP	Vectastain Elite ABC Kit	15005
@NP	Vector Laboratories	15031
@NP	USA	15052
@NP	the second day	15061
@NP	three 30-min rinses in TBST	15083
@NP	three 30-min rinses	15083
@NP	TBST	15106
@NP	the sections	15112
@NP	nickel-intensified diaminobenzidine -LRB- Sigma , St.	15146
@NP	nickel-intensified diaminobenzidine	15146
@NP	Sigma	15183
@NP	St.	15190
@NP	Louis , MO , USA -RRB- for 10 -- 15 min .	15194
@NP	Louis , MO , USA -RRB- for 10	15194
@NP	Louis , MO , USA -RRB-	15194
@NP	Louis	15194
@NP	MO	15201
@NP	USA	15205
@NP	10	15214
@NP	15 min	15217
@NP	buffer washes	15235
@NP	sections	15250
@NP	slides for light microscopic examination	15289
@NP	slides	15289
@NP	light microscopic examination	15300
@NP	electron microscopy	15347
@NP	sections	15396
@NP	2 %	15424
@NP	osmium tetroxide solution for 1 h	15427
@NP	osmium tetroxide solution	15427
@NP	1 h	15457
@NP	an ascending alcohol series	15476
@NP	durcupan resin	15521
@NP	areas of the ventral horn	15546
@NP	areas	15546
@NP	the ventral horn	15555
@NP	ultrathin sections -LRB- 70 nm thick -RRB-	15596
@NP	ultrathin sections	15596
@NP	70 nm	15616
@NP	every fifth section	15642
@NP	nickel slot grids	15693
@NP	uranyl acetate for 30 min	15728
@NP	uranyl acetate	15728
@NP	30 min	15747
@NP	the sections	15758
@NP	a CM12 Philips electron microscope	15791
@NP	Axonal counts and statistical analysis	15827
@NP	Axonal counts	15827
@NP	statistical analysis	15845
@NP	analysis of BDA-labeled RST axons	15870
@NP	analysis	15870
@NP	BDA-labeled RST axons	15882
@NP	sections of BDAlabeled RST axons	15905
@NP	sections	15905
@NP	BDAlabeled RST axons	15917
@NP	coronal sections	15961
@NP	caudal segments	15981
@NP	the spinal cord	16000
@NP	C6 -- 8 , T1 -- 4 , T8 , T12 and L1 , three sections for each segment	16017
@NP	C6 -- 8 , T1 -- 4	16017
@NP	C6	16017
@NP	8 , T1	16020
@NP	8	16020
@NP	T1	16023
@NP	4	16026
@NP	T8 , T12 and L1	16029
@NP	T8	16029
@NP	T12	16033
@NP	L1	16041
@NP	three sections for each segment	16045
@NP	three sections	16045
@NP	each segment	16064
@NP	a confocal microscopy	16084
@NP	axons in the dorsolateral or lateral funiculi	16120
@NP	axons	16120
@NP	the dorsolateral or lateral funiculi	16129
@NP	None of the labeled collaterals in the gray matter	16180
@NP	None	16180
@NP	the labeled collaterals in the gray matter	16188
@NP	the labeled collaterals	16188
@NP	the gray matter	16215
@NP	Data obtained from the histological assessments and behavioral tests	16246
@NP	Data	16246
@NP	the histological assessments and behavioral tests	16265
@NP	the histological assessments	16265
@NP	behavioral tests	16298
@NP	significant differences	16333
@NP	animal groups using either Student 's t-test or one-way ANOVA	16365
@NP	animal groups	16365
@NP	Student 's t-test or one-way ANOVA	16392
@NP	Student 's t-test	16392
@NP	Student 's	16392
@NP	one-way ANOVA	16412
@NP	All quantitative data	16427
@NP	mean ± standard deviation -LRB- SD -RRB-	16467
@NP	mean ± standard deviation	16467
@NP	SD	16492
@NP	All graphs	16497
@NP	Microsoft Excel software	16528
@NP	Results Fig. 1 .	16555
@NP	Results	16555
@NP	Fig. 1	16563
@NP	Photomicrographs of the cervical spinal cord	16571
@NP	Photomicrographs	16571
@NP	the cervical spinal cord	16591
@NP	transplanted NSFCs	16624
@NP	the lesion site and their migration	16650
@NP	the lesion site	16650
@NP	their migration	16670
@NP	the host cord 12 weeks	16691
@NP	the host cord	16691
@NP	12 weeks	16705
@NP	transplantation	16720
@NP	-LRB- A -- D -RRB- Coronal sections	16737
@NP	A -- D	16738
@NP	A	16738
@NP	D	16740
@NP	host	16768
@NP	graft site	16773
@NP	Numerous GFP-labeled NSFCs	16785
@NP	the lesion cavity	16824
@NP	the host cord	16863
@NP	interruption at the host	16886
@NP	interruption	16886
@NP	the host	16902
@NP	graft interface -LRB- dashed lines in A , C and D -RRB-	16911
@NP	graft interface	16911
@NP	lines in A , C and D	16935
@NP	lines	16935
@NP	A , C and D	16944
@NP	A modest GFAP-positive astrocytic presence	16957
@NP	the border of the transplants	17016
@NP	the border	17016
@NP	the transplants	17030
@NP	few astrocytes being detected in the graft -LRB- arrows in D -RRB-	17052
@NP	few astrocytes	17052
@NP	the graft -LRB- arrows in D -RRB-	17085
@NP	the graft	17085
@NP	arrows in D	17096
@NP	arrows	17096
@NP	D	17106
@NP	Blood vessels	17110
@NP	the graft -LRB- arrows in B and C -RRB-	17140
@NP	the graft	17140
@NP	arrows in B and C	17151
@NP	arrows	17151
@NP	B and C	17161
@NP	Some NSFCs	17171
@NP	immunoreactivity	17192
@NP	BDNF -LRB- arrowheads in yellow ; C -RRB-	17213
@NP	BDNF	17213
@NP	arrowheads in yellow ; C	17219
@NP	arrowheads	17219
@NP	yellow ; C	17233
@NP	yellow	17233
@NP	C	17241
@NP	-LRB- E -- F -RRB- Horizontal sections	17245
@NP	E -- F	17246
@NP	E	17246
@NP	F	17248
@NP	graft site	17279
@NP	Many GFP-labeled cells	17291
@NP	MAP-2 -LRB- arrows -RRB-	17338
@NP	MAP-2	17338
@NP	arrows	17345
@NP	numerous MAP-2-positive axons -LRB- arrowheads -RRB-	17375
@NP	numerous MAP-2-positive axons	17375
@NP	arrowheads	17406
@NP	host spinal cord in the lesion site	17423
@NP	host spinal cord	17423
@NP	the lesion site	17443
@NP	interpretation of the references to colour in this figure legend	17465
@NP	interpretation	17465
@NP	the references to colour in this figure legend	17483
@NP	the references	17483
@NP	colour in this figure legend	17501
@NP	colour	17501
@NP	this figure legend	17511
@NP	the reader	17531
@NP	the web version of this article	17557
@NP	the web version	17557
@NP	this article	17576
@NP	Fig. 2 .	17592
@NP	Fig.	17592
@NP	2	17597
@NP	Photomicrographs of cervical spinal cord sections showing lesion extent , host	17600
@NP	Photomicrographs	17600
@NP	cervical spinal cord sections showing lesion extent , host	17620
@NP	cervical spinal cord sections	17620
@NP	lesion extent , host	17658
@NP	lesion extent	17658
@NP	host	17673
@NP	graft integration and host immune response 12 weeks after NSFCs transplantation	17678
@NP	graft integration and host immune response	17678
@NP	12 weeks	17721
@NP	NSFCs transplantation	17736
@NP	A -- E	17760
@NP	A	17760
@NP	E	17762
@NP	Coronal -LRB- A and B -RRB-	17765
@NP	Coronal	17765
@NP	A and B	17774
@NP	A	17774
@NP	B	17780
@NP	horizontal -LRB- C -- E -RRB- sections through host -- graft site	17787
@NP	horizontal -LRB- C -- E -RRB- sections through host	17787
@NP	horizontal -LRB- C -- E -RRB- sections	17787
@NP	C -- E	17799
@NP	C	17799
@NP	E	17801
@NP	host	17821
@NP	graft site	17826
@NP	toluidine blue to	17855
@NP	toluidine	17855
@NP	the extent	17878
@NP	the lesion -LRB- dashed lines in A , C and D -RRB-	17892
@NP	the lesion	17892
@NP	lines in A , C and D	17911
@NP	lines	17911
@NP	A , C and D	17920
@NP	characteristic cytoarchitecture of NSFCs graft	17936
@NP	characteristic cytoarchitecture	17936
@NP	NSFCs graft	17971
@NP	Numerous engrafted cells	17984
@NP	Numerous	17984
@NP	cells	18003
@NP	the lesion cavity in a longitudinal direction -LRB- C -- E -RRB-	18033
@NP	the lesion cavity	18033
@NP	a longitudinal direction -LRB- C -- E -RRB-	18054
@NP	a longitudinal direction	18054
@NP	C -- E	18080
@NP	C	18080
@NP	E	18082
@NP	numerous axons -LRB- arrowheads in E -RRB-	18107
@NP	numerous axons	18107
@NP	arrowheads in E	18123
@NP	arrowheads	18123
@NP	E	18137
@NP	-LRB- F -- I -RRB- Coronal sections	18141
@NP	F -- I	18142
@NP	F	18142
@NP	I	18144
@NP	host	18172
@NP	graft site	18177
@NP	GFAP -LRB- F and G -RRB- and ED-1 -LRB- H and I -RRB-	18212
@NP	GFAP	18212
@NP	F and G	18218
@NP	F	18218
@NP	G	18224
@NP	ED-1	18231
@NP	H and I	18237
@NP	H	18237
@NP	I	18243
@NP	host immune response	18254
@NP	astrocytes -LRB- F and G -RRB- , macrophages	18286
@NP	astrocytes -LRB- F and G -RRB-	18286
@NP	astrocytes	18286
@NP	F and G	18298
@NP	F	18298
@NP	G	18304
@NP	macrophages	18308
@NP	microglia -LRB- H and I -RRB- accumulated at the graft -- host interface	18334
@NP	microglia -LRB- H and I -RRB-	18334
@NP	microglia	18334
@NP	H and I	18345
@NP	H	18345
@NP	I	18351
@NP	the graft -- host interface	18369
@NP	the graft	18369
@NP	host interface	18379
@NP	the graft	18411
@NP	Fig. 3 .	18423
@NP	Fig.	18423
@NP	3	18428
@NP	Quantitative analysis of the regenerated RST in segments	18431
@NP	Quantitative analysis	18431
@NP	the regenerated RST in segments	18456
@NP	the regenerated RST	18456
@NP	segments	18479
@NP	the graft site	18498
@NP	The number of regenerated RSTaxons	18514
@NP	The number	18514
@NP	regenerated RSTaxons	18528
@NP	the lower-cervical segments -LRB- p > 0.05 -RRB-	18574
@NP	the lower-cervical segments	18574
@NP	p > 0.05	18603
@NP	p	18603
@NP	> 0.05	18604
@NP	>	18604
@NP	0.05	18605
@NP	normal at the upperand middle-thoracic segments -LRB- p < 0.01 -RRB-	18630
@NP	normal at the upperand middle-thoracic segments	18630
@NP	the upperand	18640
@NP	p < 0.01	18679
@NP	p	18679
@NP	< 0.01	18680
@NP	<	18680
@NP	0.01	18681
@NP	No regenerated axons	18688
@NP	the lower-thoracic and lumbar segments	18726
@NP	The number of regenerated axons	18766
@NP	The number	18766
@NP	regenerated axons	18780
@NP	the distance	18813
@NP	the lesion -- graft site	18831
@NP	the lesion	18831
@NP	graft site	18842
@NP	Fig. 4 .	18855
@NP	Fig.	18855
@NP	4	18860
@NP	Photomicrographs	18863
@NP	cross sections	18883
@NP	lower-cervical and mid-thoracic segments	18901
@NP	the spinal cord illustrating BDA-labeled RST axons	18945
@NP	the spinal cord	18945
@NP	BDA-labeled RST axons	18974
@NP	A -- D -RRB- The normal RST location	18998
@NP	A -- D -RRB-	18998
@NP	A	18998
@NP	D	19000
@NP	The normal RST location	19003
@NP	organization at C7 -LRB- A and B -RRB- and T5 -LRB- C and D	19031
@NP	organization	19031
@NP	C7 -LRB- A and B -RRB- and T5 -LRB- C and D	19047
@NP	C7	19047
@NP	A and B	19051
@NP	A	19051
@NP	B	19057
@NP	T5	19064
@NP	a non-operated control animal	19089
@NP	Many small and large-caliber RST axons	19120
@NP	the dorsolateral funiculus	19173
@NP	Axonal branches	19201
@NP	lamina V -- VII of the gray matter -LRB- B -RRB-	19233
@NP	lamina V	19233
@NP	VII of the gray matter -LRB- B -RRB-	19242
@NP	VII	19242
@NP	the gray matter -LRB- B -RRB-	19249
@NP	the gray matter	19249
@NP	B	19266
@NP	-LRB- E -- H -RRB- Cross sections	19270
@NP	E -- H	19271
@NP	E	19271
@NP	H	19273
@NP	a NSFCs-engrafted animal 14 weeks	19296
@NP	a NSFCs-engrafted animal	19296
@NP	14 weeks	19321
@NP	transplantation	19336
@NP	the presence	19366
@NP	RST axons	19395
@NP	the C7 -LRB- E and F -RRB- and T5 -LRB- G and H -RRB- segments , respectively	19408
@NP	the C7	19408
@NP	E and F	19416
@NP	E	19416
@NP	F	19422
@NP	T5 -LRB- G and H -RRB- segments	19429
@NP	T5	19429
@NP	G and H	19433
@NP	G	19433
@NP	H	19439
@NP	segments	19442
@NP	the normal RST at the C7 segment	19478
@NP	the normal RST	19478
@NP	the C7 segment	19496
@NP	numerous smaller-caliber	19512
@NP	RST axons	19549
@NP	the major part	19595
@NP	the lateral funiculus at the corresponding segment -LRB- E and F -RRB-	19613
@NP	the lateral funiculus	19613
@NP	the corresponding segment -LRB- E and F -RRB-	19638
@NP	the corresponding segment	19638
@NP	E and F	19665
@NP	E	19665
@NP	F	19671
@NP	Some axons	19675
@NP	collaterals	19691
@NP	the gray matter -LRB- arrows in F -RRB-	19708
@NP	the gray matter	19708
@NP	arrows in F	19725
@NP	arrows	19725
@NP	F	19735
@NP	Axonal branches and terminals	19739
@NP	the gray matter	19785
@NP	the ventral horn -LRB- outlined area , high magnification is shown in A -RRB-	19811
@NP	the ventral horn	19811
@NP	area , high magnification	19838
@NP	A	19875
@NP	Only a few regenerated RST axons	19879
@NP	the dorsolateral funiculus	19926
@NP	the T5 segment	19956
@NP	the normal RST axons -LRB- G and H -RRB-	19984
@NP	the normal RST axons	19984
@NP	G and H	20006
@NP	G	20006
@NP	H	20012
@NP	These regenerated axons	20016
@NP	they	20078
@NP	a rostrocaudal alignment -LRB- H -RRB-	20106
@NP	a rostrocaudal alignment	20106
@NP	H	20132
@NP	Fig. 5 .	20137
@NP	Fig.	20137
@NP	5	20142
@NP	Photomicrographs of the ventral horn of lower-cervical segment	20145
@NP	Photomicrographs	20145
@NP	the ventral horn of lower-cervical segment	20165
@NP	the ventral horn	20165
@NP	lower-cervical segment	20185
@NP	regenerated synapses of the RST axons 14 weeks	20216
@NP	regenerated synapses	20216
@NP	the RST axons 14 weeks	20240
@NP	the RST axons	20240
@NP	14 weeks	20254
@NP	NSFCs transplantation	20269
@NP	-LRB- A and D -RRB- Many BDA-labeled axonal branches and terminals	20292
@NP	-LRB- A and D -RRB- Many BDA-labeled axonal branches	20292
@NP	-LRB- A and D -RRB-	20292
@NP	A	20293
@NP	D	20299
@NP	Many BDA-labeled axonal branches	20302
@NP	terminals	20339
@NP	the ventral horn	20375
@NP	B	20394
@NP	C and E -- F	20396
@NP	C and E	20396
@NP	F	20404
@NP	High magnification	20407
@NP	several axonal branches	20439
@NP	many varicosities that resemble terminal boutons	20468
@NP	many varicosities	20468
@NP	terminal boutons	20500
@NP	which	20518
@NP	motoneuron soma -LRB- stars in E and F -RRB-	20535
@NP	motoneuron soma	20535
@NP	stars in E and F	20552
@NP	stars	20552
@NP	E and F	20561
@NP	Some	20571
@NP	it	20612
@NP	they	20630
@NP	pre-synaptic boutons -LRB- yellow , indicated by arrowheads in E and F -RRB-	20642
@NP	pre-synaptic boutons	20642
@NP	yellow , indicated by arrowheads in E and F	20664
@NP	yellow	20664
@NP	indicated by arrowheads in E and F	20672
@NP	indicated	20672
@NP	arrowheads in E and F	20685
@NP	arrowheads	20685
@NP	E and F	20699
@NP	interpretation of the references to colour in this figure legend	20714
@NP	interpretation	20714
@NP	the references to colour in this figure legend	20732
@NP	the references	20732
@NP	colour in this figure legend	20750
@NP	colour	20750
@NP	this figure legend	20760
@NP	the reader	20780
@NP	the web version of this article	20806
@NP	the web version	20806
@NP	this article	20825
@NP	Fig. 6 .	20841
@NP	Fig.	20841
@NP	6	20846
@NP	Electron micrographs	20849
@NP	BDA-labeled RST axonal terminals	20873
@NP	reestablishment of synaptic connections with their spinal targets 14 weeks	20914
@NP	reestablishment	20914
@NP	synaptic connections with their spinal targets 14 weeks	20933
@NP	synaptic connections	20933
@NP	their spinal targets	20959
@NP	14 weeks	20980
@NP	NSFCs transplantation	20995
@NP	Ultrathin sections	21018
@NP	the ventral horn	21056
@NP	C6 segment	21076
@NP	NSFCs-engrafted -LRB- A -- C -RRB- or lesion-matrix-only -LRB- D -RRB- rats	21090
@NP	A -- C	21107
@NP	A	21107
@NP	C	21109
@NP	D	21135
@NP	A and B	21145
@NP	BDA-labeled axon terminals	21162
@NP	synaptic contacts -LRB- arrowheads -RRB-	21202
@NP	synaptic contacts	21202
@NP	arrowheads	21221
@NP	neuronal soma -LRB- A -RRB- or dendritic branches -LRB- B -RRB-	21238
@NP	neuronal soma	21238
@NP	A	21253
@NP	dendritic branches	21259
@NP	B	21279
@NP	Morphological and immunocytochemical properties	21287
@NP	a BDA-labeled RST axon	21338
@NP	The appearance of loose and thin myelin sheaths -LRB- arrows -RRB-	21362
@NP	The appearance	21362
@NP	loose and thin myelin sheaths -LRB- arrows -RRB-	21380
@NP	loose and thin myelin sheaths	21380
@NP	arrows	21411
@NP	an incomplete myelin repair	21430
@NP	Ultrastructural cytoarchitecture	21463
@NP	the ventral horn	21499
@NP	C6 segment	21519
@NP	a lesion-matrix-only rat	21533
@NP	Neuron-related structures	21559
@NP	an astrocyte	21613
@NP	spongy extracellular matrix -LRB- asterisk -RRB-	21627
@NP	spongy extracellular matrix	21627
@NP	asterisk	21656
@NP	aggregated filamentous -LRB- arrows -RRB-	21670
@NP	A , axonal terminal ; As , astrocytic profile	21703
@NP	axonal terminal	21706
@NP	D ; dendritic profile ; M , myelinated axon ; N , nucleus	21747
@NP	D ; dendritic profile	21747
@NP	D	21747
@NP	dendritic profile	21750
@NP	M , myelinated axon	21769
@NP	M	21769
@NP	myelinated axon	21772
@NP	N , nucleus	21789
@NP	N	21789
@NP	nucleus	21792
@NP	Fig. 7 .	21802
@NP	Fig.	21802
@NP	7	21807
@NP	Photographs	21810
@NP	forepaw posture	21830
@NP	the same lesion-matrix-only	21849
@NP	A -- C	21878
@NP	A	21878
@NP	C	21880
@NP	NSFCs-engrafted animals	21887
@NP	D -- F	21912
@NP	D	21912
@NP	F	21914
@NP	different times	21920
@NP	engraftment	21942
@NP	A and D	21956
@NP	A	21956
@NP	D	21962
@NP	1 week	21965
@NP	engraftment	21978
@NP	all the digits on the right forepaw -LRB- ipsilateral to the lesion site -RRB-	21991
@NP	all the digits on the right forepaw	21991
@NP	all the digits	21991
@NP	the right forepaw	22009
@NP	ipsilateral to the lesion site	22028
@NP	ipsilateral	22028
@NP	the lesion site	22043
@NP	the lesion-matrix-only -LRB- A -RRB-	22075
@NP	the NSFCs-engrafted animal -LRB- D -RRB-	22116
@NP	the NSFCs-engrafted animal	22116
@NP	D	22144
@NP	B and E	22149
@NP	B	22149
@NP	E	22155
@NP	6 weeks	22158
@NP	engraftment	22172
@NP	the digits on the right forepaw	22185
@NP	the digits	22185
@NP	the right forepaw	22199
@NP	further flexed in the same lesion-matrix-only animal -LRB- B -RRB-	22222
@NP	further	22222
@NP	the same lesion-matrix-only animal -LRB- B -RRB-	22240
@NP	the same lesion-matrix-only animal	22240
@NP	B	22276
@NP	the digits	22284
@NP	the same lesion plus engrafted animal -LRB- E -RRB-	22318
@NP	the same lesion	22318
@NP	animal -LRB- E -RRB-	22349
@NP	animal	22349
@NP	E	22357
@NP	C and F	22362
@NP	C	22362
@NP	F	22368
@NP	1 week	22371
@NP	the DLF at right C2	22384
@NP	the DLF	22384
@NP	right C2	22395
@NP	13 weeks after engraftment	22405
@NP	13 weeks	22405
@NP	engraftment	22420
@NP	flexion of the forepaw	22434
@NP	flexion	22434
@NP	the forepaw	22445
@NP	the lesion lesion-matrix-only animal -LRB- C -RRB-	22469
@NP	the lesion lesion-matrix-only animal	22469
@NP	C	22507
@NP	previous forepaw recovery	22517
@NP	forelimb flexion in the NSFCsengrafted animal -LRB- F -RRB-	22570
@NP	forelimb flexion	22570
@NP	the NSFCsengrafted animal -LRB- F -RRB-	22590
@NP	the NSFCsengrafted animal	22590
@NP	F	22617
@NP	Fig. 8 .	22622
@NP	Fig.	22622
@NP	8	22627
@NP	Behavioral analysis of forelimb usage .	22630
@NP	Behavioral analysis	22630
@NP	forelimb usage	22653
@NP	surgery	22676
@NP	-LRB- A -RRB- the lesionmatrix	22685
@NP	-LRB- A -RRB-	22685
@NP	the lesionmatrix	22689
@NP	only -LRB- n = 14 -RRB- and -LRB- B -RRB- the lesion	22707
@NP	only -LRB- n = 14 -RRB-	22707
@NP	only	22707
@NP	n	22713
@NP	14	22715
@NP	B	22724
@NP	the lesion	22727
@NP	NSFCs-engrafted animals -LRB- n = 26 -RRB-	22743
@NP	NSFCs-engrafted animals	22743
@NP	n	22768
@NP	26	22770
@NP	the same percentage of forelimb use	22784
@NP	the same percentage	22784
@NP	forelimb use	22807
@NP	cylinder wall exploration using right	22827
@NP	cylinder wall exploration	22827
@NP	right	22859
@NP	forepaws	22873
@NP	both forepaws	22899
@NP	Neither group	22929
@NP	use of the right forelimb	22953
@NP	use	22953
@NP	the right forelimb	22960
@NP	the first 2 weeks	22986
@NP	engraftment	23010
@NP	-LRB- A -RRB- No return of function	23023
@NP	-LRB- A -RRB- No return	23023
@NP	-LRB- A -RRB-	23023
@NP	No return	23027
@NP	function	23040
@NP	the right forelimb of lesion-matrix-only animals	23062
@NP	the right forelimb	23062
@NP	lesion-matrix-only animals	23084
@NP	-LRB- B -RRB- Recovery of use of the right forepaw alone or both forepaws	23112
@NP	-LRB- B -RRB-	23112
@NP	use of the right forepaw alone or both forepaws	23128
@NP	use	23128
@NP	the right forepaw alone or both forepaws	23135
@NP	the right forepaw alone	23135
@NP	both forepaws	23162
@NP	the engrafted animals from week 3	23204
@NP	the	23204
@NP	animals	23218
@NP	week 3	23231
@NP	This recovery	23239
@NP	a plateau between weeks 6 and 7 , which remained constant to week 12	23274
@NP	a plateau	23274
@NP	weeks 6 and 7 , which remained constant to week 12	23292
@NP	weeks 6 and 7	23292
@NP	week 12	23334
@NP	Fig. 9 .	23344
@NP	Fig.	23344
@NP	9	23349
@NP	Photographs demonstrating the forelimb use 12 weeks after engraftment .	23352
@NP	Photographs	23352
@NP	the forelimb use	23378
@NP	12 weeks	23395
@NP	engraftment	23410
@NP	-LRB- A -RRB- The right forelimb in lesion-matrix-only animals	23423
@NP	-LRB- A -RRB- The right forelimb	23423
@NP	-LRB- A -RRB-	23423
@NP	The right forelimb	23427
@NP	lesion-matrix-only animals	23449
@NP	spontaneous vertical exploration -LRB- arrow -RRB-	23519
@NP	spontaneous vertical exploration	23519
@NP	arrow	23553
@NP	-LRB- B -- D -RRB- NSFCs-engrafted animal	23561
@NP	B -- D	23562
@NP	B	23562
@NP	D	23564
@NP	inactivation by muscimol	23615
@NP	inactivation	23615
@NP	muscimol	23631
@NP	-LRB- B -RRB- Prior to injection of muscimol	23641
@NP	-LRB- B -RRB-	23641
@NP	injection of muscimol	23654
@NP	injection	23654
@NP	muscimol	23667
@NP	the animal	23677
@NP	both paws	23700
@NP	the cylinder	23721
@NP	the recovered right	23749
@NP	motor activity -LRB- arrow -RRB-	23778
@NP	motor activity	23778
@NP	arrow	23794
@NP	injection of muscimol into the left RN	23816
@NP	injection	23816
@NP	muscimol into the left RN	23829
@NP	muscimol	23829
@NP	the left RN	23843
@NP	the right forelimb	23856
@NP	a	23891
@NP	posture -LRB- arrow -RRB-	23900
@NP	posture	23900
@NP	arrow	23909
@NP	the recovered function	23933
@NP	the drug-induced blockade	23973
@NP	The animal	24004
@NP	the use of the right paw	24024
@NP	the use	24024
@NP	the right paw	24035
@NP	the wall	24069
@NP	the effects of the drug	24083
@NP	the effects	24083
@NP	the drug	24098
@NP	48 h	24118
@NP	arrow	24130
@NP	Fig. 10 .	24139
@NP	Fig.	24139
@NP	10	24144
@NP	Quantitative evaluation	24148
@NP	forelimb functional recovery in lesion	24175
@NP	forelimb functional recovery	24175
@NP	lesion	24207
@NP	matrix-only and NSFCs-engrafted animals	24214
@NP	irreversible and reversible lesions 12 weeks	24270
@NP	irreversible and reversible lesions	24270
@NP	12 weeks	24306
@NP	engraftment	24321
@NP	-LRB- A -RRB- DLF at the right C2 segment	24334
@NP	-LRB- A -RRB-	24334
@NP	the right C2 segment	24345
@NP	little effect on the lesion-matrix-only animals -LRB- n = 6 , p > 0.05 -RRB-	24370
@NP	little effect	24370
@NP	the lesion-matrix-only animals -LRB- n = 6 , p > 0.05 -RRB-	24387
@NP	the lesion-matrix-only animals	24387
@NP	n = 6 , p > 0.05	24419
@NP	n	24419
@NP	= 6 , p > 0.05	24420
@NP	= 6 , p >	24420
@NP	6 , p	24421
@NP	6	24421
@NP	p	24424
@NP	0.05	24426
@NP	contrast	24440
@NP	the DLF procedure	24450
@NP	the functional recovery	24486
@NP	the subgroup of engraftment animals	24513
@NP	the subgroup	24513
@NP	engraftment animals	24529
@NP	up to 4 weeks evaluated -LRB- n = 6 , p < 0.01 -RRB-	24553
@NP	up to 4 weeks	24553
@NP	n = 6 , p < 0.01	24578
@NP	n	24578
@NP	= 6 , p < 0.01	24579
@NP	= 6 , p <	24579
@NP	6 , p	24580
@NP	6	24580
@NP	p	24583
@NP	0.01	24585
@NP	-LRB- C -RRB- Injection of saline only into the left RN	24592
@NP	-LRB- C -RRB-	24592
@NP	saline only into the left RN	24609
@NP	saline only	24609
@NP	the left RN	24626
@NP	forelimb usage of NSFCs-engrafted animals -LRB- n = 6 , p > 0.05 -RRB-	24653
@NP	forelimb usage	24653
@NP	NSFCs-engrafted animals -LRB- n = 6 , p > 0.05 -RRB-	24671
@NP	NSFCs-engrafted animals	24671
@NP	n = 6 , p > 0.05	24696
@NP	n	24696
@NP	= 6 , p > 0.05	24697
@NP	= 6 , p >	24697
@NP	6 , p	24698
@NP	6	24698
@NP	p	24701
@NP	0.05	24703
@NP	-LRB- D -RRB- Injection of muscimol into the left RN of NSFCs-engrafted animals	24710
@NP	Injection	24714
@NP	muscimol into the left RN of NSFCs-engrafted animals	24727
@NP	muscimol	24727
@NP	the left RN of NSFCs-engrafted animals	24741
@NP	the left RN	24741
@NP	NSFCs-engrafted animals	24756
@NP	n	24781
@NP	6	24783
@NP	right forelimb dysfunction	24793
@NP	inactivation	24827
@NP	12 h after injection , p < 0.01	24841
@NP	12 h	24841
@NP	injection , p < 0.01	24852
@NP	injection	24852
@NP	p < 0.01	24863
@NP	p <	24863
@NP	p	24863
@NP	0.01	24865
@NP	This dysfunction	24872
@NP	a 48-h recovery period	24915
@NP	Survival and integration	24940
@NP	GFP-labeled NSFCs	24968
@NP	engraftment	24992
@NP	injured host spinal cord Spinal cord tissues	25009
@NP	the lesion-matrix-only	25059
@NP	lesion plus NSFCs-engrafted groups	25086
@NP	lesion	25086
@NP	NSFCs-engrafted groups	25098
@NP	lesion extent	25139
@NP	the transplant survival	25154
@NP	scar tissue formation	25179
@NP	the host immune response	25205
@NP	The lesion extents	25231
@NP	the right dorsolateral and lateral funiculi -LRB- containing the RST -RRB-	25259
@NP	the right dorsolateral and lateral funiculi	25259
@NP	the right dorsolateral	25259
@NP	lateral funiculi	25286
@NP	the RST	25315
@NP	regions	25336
@NP	the right ventral funiculus and gray matter	25347
@NP	Figs. 1A , and 2A , F and H	25392
@NP	Figs.	25392
@NP	1A	25398
@NP	2A , F and H	25406
@NP	NSFCs	25430
@NP	the lesion cavity	25454
@NP	the margins	25488
@NP	the	25503
@NP	cord	25518
@NP	interruption	25531
@NP	cysts or scar tissue	25547
@NP	the graft -- host interface -LRB- Figs. 1A -- D and 2A -- E -RRB-	25571
@NP	the graft	25571
@NP	host interface	25581
@NP	Figs. 1A	25597
@NP	D and 2A -- E	25606
@NP	D and 2A	25606
@NP	E	25615
@NP	A few cells	25619
@NP	BDNF -LRB- Fig. 1C -RRB-	25659
@NP	BDNF	25659
@NP	Fig. 1C	25665
@NP	Most of the engrafted NSFCs	25675
@NP	Most	25675
@NP	the engrafted NSFCs	25683
@NP	the	25683
@NP	NSFCs	25697
@NP	mature neuronal makers such as MAP-2 -LRB- microtubule-associated protein -RRB-	25725
@NP	mature neuronal makers	25725
@NP	MAP-2 -LRB- microtubule-associated protein -RRB-	25756
@NP	MAP-2	25756
@NP	microtubule-associated protein	25763
@NP	numerous many MAP-2-positive axons	25817
@NP	host spinal cord at the graft site -LRB- Figs. 1E and F -RRB-	25857
@NP	host spinal cord	25857
@NP	the graft site -LRB- Figs. 1E and F -RRB-	25877
@NP	the graft site	25877
@NP	Figs. 1E and F	25893
@NP	Figs. 1E	25893
@NP	F	25906
@NP	the host immune response	25926
@NP	additional immunocytochemical studies	25952
@NP	anti-GFAP antibody	26012
@NP	astrocytes and ED-1 antibody	26043
@NP	activated macrophages and microglia	26084
@NP	These studies	26121
@NP	astrocytes	26148
@NP	Figs. 1D and 2F and G	26160
@NP	Figs. 1D	26160
@NP	2F and G	26173
@NP	macrophages and activated microglia -LRB- Figs. 2H and I -RRB-	26184
@NP	macrophages and activated microglia	26184
@NP	macrophages	26184
@NP	activated microglia	26200
@NP	Figs. 2H and I	26221
@NP	the graft -- host interface	26240
@NP	the graft	26240
@NP	host interface	26250
@NP	the graft	26277
@NP	The good graft survival and mild immune responses	26288
@NP	The good graft survival	26288
@NP	mild immune responses	26316
@NP	the efficient cyclosporine immunosuppression protocols	26357
@NP	the inhibition of inflammation	26419
@NP	the inhibition	26419
@NP	inflammation	26437
@NP	penicillin	26455
@NP	The engrafted NSFCs	26467
@NP	The	26467
@NP	NSFCs	26481
@NP	RST axonal regeneration	26506
@NP	synaptic connections	26546
@NP	their spinal targets	26572
@NP	The effect of NSFCs-engraftment on axotomized RST axonal regeneration	26593
@NP	The effect	26593
@NP	NSFCs-engraftment on axotomized RST axonal regeneration	26607
@NP	NSFCs-engraftment	26607
@NP	axotomized RST axonal regeneration	26628
@NP	the previous data -LRB- Xiao et al. , 2005 -RRB-	26678
@NP	the previous data	26678
@NP	Xiao	26697
@NP	et al. , 2005	26702
@NP	et al.	26702
@NP	2005	26710
@NP	the repeated description	26735
@NP	the present study	26761
@NP	the quantitative analysis	26791
@NP	the distance that RST axons regenerated into segments	26820
@NP	the distance	26820
@NP	RST axons	26838
@NP	segments	26865
@NP	the lesion -- graft site	26884
@NP	the lesion	26884
@NP	graft site	26895
@NP	all lesion-matrix-only animals	26910
@NP	no BDA-labeled RST axons	26942
@NP	the dorsolateral funiculus of the host spinal cord caudal	26984
@NP	the dorsolateral funiculus	26984
@NP	the host spinal cord caudal	27014
@NP	the lesion	27045
@NP	all eight BDA tracing NSFCs-engrafted animals	27060
@NP	all eight BDA	27060
@NP	NSFCs-engrafted animals	27082
@NP	regenerated axons	27107
@NP	caudal	27136
@NP	the lesion site	27146
@NP	five animals	27166
@NP	BDA-labeled RST axons	27180
@NP	mid-thoracic segments -LRB- T5 -- 6 -RRB- , 4 -- 8 segments caudal	27215
@NP	mid-thoracic segments -LRB- T5 -- 6 -RRB-	27215
@NP	mid-thoracic segments	27215
@NP	T5 -- 6	27238
@NP	T5	27238
@NP	6	27241
@NP	4 -- 8 segments caudal	27245
@NP	4	27245
@NP	8 segments	27247
@NP	the transplant	27268
@NP	Quantitative analysis	27284
@NP	regenerated RST axons	27315
@NP	number the farther caudal to the graft -LRB- Fig. 3 -RRB-	27350
@NP	number the farther caudal to the graft	27350
@NP	number	27350
@NP	the graft	27379
@NP	Fig. 3	27390
@NP	the C6 -- 7 segments of transplanted animals	27402
@NP	the C6	27402
@NP	7 segments of transplanted animals	27409
@NP	7 segments	27409
@NP	transplanted animals	27423
@NP	the number of regenerated RST axons	27445
@NP	the number	27445
@NP	regenerated RST axons	27459
@NP	RST axons	27504
@NP	the T4 -- 5 segments	27518
@NP	the T4	27518
@NP	5 segments	27525
@NP	fewer regenerated axons	27537
@NP	comparison	27574
@NP	the controls -LRB- Fig. 4 -RRB-	27588
@NP	the controls	27588
@NP	Fig. 4	27602
@NP	the potential of regenerated RST axons	27623
@NP	the potential	27623
@NP	regenerated RST axons	27640
@NP	synaptic connections	27677
@NP	their spinal targets	27703
@NP	the distribution of BDA-labeled collaterals and terminals in the gray matter	27725
@NP	the distribution	27725
@NP	BDA-labeled collaterals and terminals in the gray matter	27745
@NP	BDA-labeled collaterals and terminals	27745
@NP	the gray matter	27786
@NP	segments caudal to the lesion -- graft site	27818
@NP	segments	27818
@NP	the lesion	27837
@NP	graft site	27848
@NP	the caudal segments adjacent to the lesion -- graft site	27863
@NP	the caudal segments	27863
@NP	the lesion -- graft site	27895
@NP	the lesion	27895
@NP	graft site	27906
@NP	many collaterals	27918
@NP	V -- VII of the ipsilateral gray matter -LRB- Figs. 4C and D -RRB-	27971
@NP	V	27971
@NP	VII of the ipsilateral gray matter -LRB- Figs. 4C and D -RRB-	27973
@NP	VII	27973
@NP	the ipsilateral gray matter -LRB- Figs. 4C and D -RRB-	27980
@NP	the ipsilateral gray matter	27980
@NP	Figs. 4C and D	28009
@NP	Figs. 4C	28009
@NP	D	28022
@NP	Many BDA-labeled branches	28026
@NP	laminae V -- VII , with some terminal -- bouton-like structures	28066
@NP	VII , with some	28076
@NP	VII	28076
@NP	some	28086
@NP	close apposition	28127
@NP	interneurons	28147
@NP	the C6 -- C7 segments	28164
@NP	the C6	28164
@NP	C7 segments	28171
@NP	many axonal branches and terminals	28184
@NP	many axonal branches	28184
@NP	terminals	28209
@NP	the ventral horn -LRB- laminae VIII -- IX -RRB- -LRB- Fig. 5 -RRB-	28245
@NP	the ventral horn -LRB- laminae VIII -- IX -RRB-	28245
@NP	the ventral horn	28245
@NP	laminae VIII -- IX	28263
@NP	laminae	28263
@NP	VIII -- IX	28271
@NP	Fig. 5	28281
@NP	biotin -- FITC/synapsin double-labeled sections	28293
@NP	biotin	28293
@NP	FITC/synapsin double-labeled sections	28300
@NP	FITC/synapsin	28300
@NP	double-labeled sections	28314
@NP	some axonal branches	28339
@NP	the somata of motoneurons	28371
@NP	the somata	28371
@NP	motoneurons	28385
@NP	presynaptic boutons -LRB- Figs. 5E -- F -RRB-	28408
@NP	presynaptic boutons	28408
@NP	Figs. 5E -- F	28429
@NP	Figs. 5E	28429
@NP	F	28438
@NP	the more caudal segments	28445
@NP	fewer BDA-labeled collaterals	28471
@NP	the mid-thoracic level	28516
@NP	no collaterals	28540
@NP	the gray matter	28568
@NP	a few BDA-labeled RST axons	28594
@NP	the dorsolateral funiculus -LRB- Figs. 4G and H -RRB-	28644
@NP	the dorsolateral funiculus	28644
@NP	Figs. 4G and H	28672
@NP	Figs. 4G	28672
@NP	H	28685
@NP	Ultrastructural analysis	28689
@NP	NSFCs-engraftment	28731
@NP	the RST axons ' regeneration and reestablishment of synaptic connections	28758
@NP	the RST axons ' regeneration and reestablishment	28758
@NP	the RST axons '	28758
@NP	synaptic connections	28809
@NP	ventral horn neurons of the distal cervical spinal cord	28835
@NP	ventral horn neurons	28835
@NP	the distal cervical spinal cord	28859
@NP	BDA-labeled terminals	28892
@NP	synapses on neuronal soma or dendrites	28944
@NP	synapses	28944
@NP	neuronal soma or dendrites	28956
@NP	the ventral horn of C6 segment of engrafted rats -LRB- Figs. 6A and B -RRB-	28986
@NP	the ventral horn	28986
@NP	C6 segment of engrafted rats -LRB- Figs. 6A and B -RRB-	29006
@NP	C6 segment	29006
@NP	rats -LRB- Figs. 6A and B -RRB-	29030
@NP	rats	29030
@NP	Figs. 6A and B	29036
@NP	Figs. 6A	29036
@NP	B	29049
@NP	remyelination	29068
@NP	place	29087
@NP	all BDA-labeled axons	29096
@NP	myelin repair	29128
@NP	incomplete	29149
@NP	the loose and thin myelin sheaths -LRB- Fig. 6C -RRB-	29188
@NP	the loose and thin myelin sheaths	29188
@NP	Fig. 6C	29223
@NP	The above regenerated synapses	29233
@NP	the C6	29288
@NP	7 segments	29295
@NP	four NSFCs-engrafted animals used for electron microscopic examination	29309
@NP	four NSFCs-engrafted animals	29309
@NP	electron microscopic examination	29347
@NP	contrast	29384
@NP	no BDA-labeled axons or terminals	29394
@NP	no BDA-labeled axons	29394
@NP	terminals	29418
@NP	the ventral horn of C6 segment	29442
@NP	the ventral horn	29442
@NP	C6 segment	29462
@NP	lesion-matrix-only animals	29476
@NP	astrocytes	29518
@NP	masses of filamentous or extracellular matrix -LRB- Fig. 6D -RRB-	29530
@NP	masses	29530
@NP	filamentous or extracellular matrix -LRB- Fig. 6D -RRB-	29540
@NP	filamentous or extracellular matrix	29540
@NP	Fig. 6D	29577
@NP	NSFCs	29597
@NP	functional recovery Forelimb	29611
@NP	different times	29668
@NP	engraftment	29690
@NP	1 week	29703
@NP	engraftment	29716
@NP	prominent deficits	29729
@NP	elbow and digit extension	29761
@NP	the right forelimb	29790
@NP	both lesion-matrix-only -LRB- Fig. 7A -RRB- and NSFCs-engrafted groups	29812
@NP	lesion-matrix-only -LRB- Fig. 7A -RRB-	29817
@NP	lesion-matrix-only	29817
@NP	Fig. 7A	29837
@NP	NSFCs-engrafted groups	29850
@NP	Fig. 7D	29874
@NP	This forepaw flexion	29884
@NP	12 weeks	29925
@NP	all lesion-matrix-only animals -LRB- Fig. 7B -RRB-	29937
@NP	all lesion-matrix-only animals	29937
@NP	Fig. 7B	29969
@NP	contrast	29982
@NP	partial reextension of proximal and distal forelimb	29992
@NP	partial reextension	29992
@NP	proximal and distal forelimb	30015
@NP	some NSFCs-engrafted animals early as 2 weeks	30056
@NP	some NSFCs-engrafted animals	30056
@NP	2 weeks	30094
@NP	engraftment	30108
@NP	the 6th week after NSFCs engraftment	30134
@NP	the 6th week	30134
@NP	NSFCs engraftment	30153
@NP	full extension of the right forepaw	30172
@NP	full extension	30172
@NP	the right forepaw	30190
@NP	73 % -LRB- n = 19 -RRB-	30220
@NP	73 %	30220
@NP	n	30225
@NP	19	30227
@NP	the animals -LRB- total n = 26 -RRB- evaluated	30234
@NP	the animals	30234
@NP	total n	30247
@NP	26	30255
@NP	Fig. 7E	30270
@NP	Seven engrafted animals	30280
@NP	Seven	30280
@NP	animals	30296
@NP	considerable improvement	30319
@NP	elbow and digit extension	30347
@NP	the end of the 12th week	30376
@NP	the end	30376
@NP	the 12th week	30387
@NP	Weekly observation of spontaneous vertical exploration	30402
@NP	Weekly observation	30402
@NP	spontaneous vertical exploration	30424
@NP	corresponding functional recovery	30478
@NP	the 1st week after transplantation	30520
@NP	the 1st week	30520
@NP	transplantation	30539
@NP	animals in both groups	30556
@NP	animals	30556
@NP	both groups	30567
@NP	95 %	30606
@NP	their left forelimb , rarely -LRB- 5 % -RRB-	30614
@NP	their left forelimb , rarely	30614
@NP	their left forelimb	30614
@NP	5 %	30643
@NP	forelimbs	30658
@NP	the wall -LRB- Fig. 8 -RRB-	30679
@NP	the wall	30679
@NP	Fig. 8	30689
@NP	No return of function	30698
@NP	No return	30698
@NP	function	30711
@NP	any	30733
@NP	the lesion-matrix-only animals through the 12 - week observation period	30740
@NP	lesion-matrix-only animals	30744
@NP	the 12	30779
@NP	Figs. 8A and 9A	30812
@NP	Figs. 8A	30812
@NP	9A	30825
@NP	the NSFCsengrafted animals	30838
@NP	the use of both forepaws	30866
@NP	the use	30866
@NP	both forepaws	30877
@NP	28 %	30919
@NP	the 2nd week	30926
@NP	limited functional recovery -LRB- Fig. 8B -RRB-	30951
@NP	limited functional recovery	30951
@NP	Fig. 8B	30980
@NP	the 3rd week on	30995
@NP	the 3rd week	30995
@NP	use of the right forelimb alone -LRB- 3 % -RRB-	31012
@NP	use	31012
@NP	the right forelimb alone -LRB- 3 % -RRB-	31019
@NP	the right forelimb alone	31019
@NP	the right forelimb	31019
@NP	3 %	31045
@NP	the NSFCs-engrafted animals -LRB- Fig. 8B -RRB-	31062
@NP	the NSFCs-engrafted animals	31062
@NP	Fig. 8B	31091
@NP	the end of 6 weeks	31104
@NP	the end	31104
@NP	6 weeks	31115
@NP	the use of the right forepaw alone and both forepaws	31124
@NP	the use	31124
@NP	the right forepaw alone and both forepaws	31135
@NP	the right forepaw alone	31135
@NP	both forepaws	31163
@NP	80 % , which closely approximated the preoperative level -LRB- 90 % -RRB-	31196
@NP	80 %	31196
@NP	the preoperative level -LRB- 90 % -RRB-	31228
@NP	the preoperative level	31228
@NP	90 %	31252
@NP	This level of recovery	31258
@NP	This level	31258
@NP	recovery	31272
@NP	the remaining observation period -LRB- Figs. 8B and 9B -RRB-	31304
@NP	the remaining observation period	31304
@NP	Figs. 8B and 9B	31338
@NP	Figs. 8B	31338
@NP	9B	31351
@NP	recovery in NSFCs-engrafted animals	31365
@NP	recovery	31365
@NP	NSFCs-engrafted animals	31377
@NP	irreversible and reversible lesions of regenerated RST	31418
@NP	irreversible and reversible lesions	31418
@NP	regenerated RST	31457
@NP	the recovery of forelimb function	31496
@NP	the recovery	31496
@NP	forelimb function	31512
@NP	NSFCs-engrafted animals	31539
@NP	the RST axonal regeneration and reinnervation	31581
@NP	the RST axonal regeneration	31581
@NP	reinnervation	31613
@NP	the regenerated RST axons	31628
@NP	a second DLF	31683
@NP	the right C2 segment	31699
@NP	injection of muscimol	31746
@NP	injection	31746
@NP	muscimol	31759
@NP	the left RN	31773
@NP	The second DLF	31786
@NP	little effect	31805
@NP	the flexion	31822
@NP	the forepaw and forelimb usage	31837
@NP	the lesion-matrix-only animals -LRB- p > 0.05 , Figs. 7C and 10A -RRB-	31871
@NP	the lesion-matrix-only animals	31871
@NP	p	31903
@NP	> 0.05 , Figs. 7C and 10A	31904
@NP	>	31904
@NP	0.05	31905
@NP	Figs. 7C and 10A	31911
@NP	all six	31937
@NP	animals , the restored extension of the forepaw	31955
@NP	animals	31955
@NP	the restored extension of the forepaw	31964
@NP	the restored extension	31964
@NP	the forepaw	31990
@NP	use	32025
@NP	up to 4 weeks	32059
@NP	the operation -LRB- p < 0.01 , Figs. 7F and 10B -RRB-	32079
@NP	the operation	32079
@NP	p	32094
@NP	< 0.01 , Figs. 7F and 10B	32095
@NP	<	32095
@NP	0.01	32096
@NP	Figs. 7F and 10B	32102
@NP	the prominent deficits in elbow and digit extension of the right forelimb	32132
@NP	the prominent deficits	32132
@NP	elbow and digit extension of the right forelimb	32158
@NP	elbow and digit extension	32158
@NP	the right forelimb	32187
@NP	following injection	32216
@NP	the neural	32239
@NP	agent muscimol	32259
@NP	the magnocellular portion of the left RN of six NSFCs-engrafted animals	32279
@NP	the magnocellular portion	32279
@NP	the left RN of six NSFCs-engrafted animals	32308
@NP	the left RN	32308
@NP	six NSFCs-engrafted animals	32323
@NP	Flexion of the right forelimb	32352
@NP	Flexion	32352
@NP	the right forelimb	32363
@NP	the animals	32406
@NP	This dysfunction	32447
@NP	18 -- 24 h -LRB- Fig. 9C -RRB-	32478
@NP	18	32478
@NP	24 h -LRB- Fig. 9C -RRB-	32481
@NP	Fig. 9C	32487
@NP	normal posture	32506
@NP	Fig. 9D	32541
@NP	Forelimb use by the NSFCs - engrafted animals receiving saline alone or muscimol	32551
@NP	Forelimb use	32551
@NP	the NSFCs - engrafted animals receiving saline alone or muscimol	32567
@NP	the NSFCs	32567
@NP	animals	32588
@NP	saline alone or muscimol	32606
@NP	saline alone	32606
@NP	muscimol	32622
@NP	recovery	32667
@NP	the drug -LRB- Figs. 10C and D -RRB-	32681
@NP	the drug	32681
@NP	Figs. 10C and D	32691
@NP	Figs. 10C	32691
@NP	D	32705
@NP	Behavioral data	32709
@NP	the animals	32743
@NP	right forelimb use	32760
@NP	12 h	32783
@NP	injection of muscimol -LRB- p < 0.01 -RRB-	32794
@NP	injection	32794
@NP	muscimol -LRB- p < 0.01 -RRB-	32807
@NP	muscimol	32807
@NP	p < 0.01	32817
@NP	p	32817
@NP	< 0.01	32818
@NP	<	32818
@NP	0.01	32819
@NP	48 h after the injection	32829
@NP	48 h	32829
@NP	the injection	32840
@NP	pre-injection levels of function -LRB- p > 0.05 -RRB- -LRB- Fig. 10D -RRB-	32872
@NP	pre-injection levels	32872
@NP	function -LRB- p > 0.05 -RRB- -LRB- Fig. 10D -RRB-	32896
@NP	function -LRB- p > 0.05 -RRB-	32896
@NP	function	32896
@NP	p > 0.05	32906
@NP	p	32906
@NP	> 0.05	32907
@NP	>	32907
@NP	0.05	32908
@NP	Fig. 10D	32915
@NP	Similar results	32926
@NP	the animals	32961
@NP	an additional injection -LRB- p > 0.05 -RRB-	32982
@NP	an additional injection	32982
@NP	p > 0.05	33007
@NP	p	33007
@NP	> 0.05	33008
@NP	>	33008
@NP	0.05	33009
@NP	Six NSFCsengrafted animals that received saline injections to the RN	33016
@NP	Six NSFCsengrafted animals	33016
@NP	saline injections	33057
@NP	the RN	33078
@NP	deficits of forelimb posture -LRB- p > 0.05 -RRB-	33101
@NP	deficits	33101
@NP	forelimb posture -LRB- p > 0.05 -RRB-	33113
@NP	forelimb posture	33113
@NP	p > 0.05	33131
@NP	p	33131
@NP	> 0.05	33132
@NP	>	33132
@NP	0.05	33133
@NP	neuronal inactivation , not a mechanical or osmotic effect of drug injection ,	33153
@NP	neuronal inactivation	33153
@NP	a mechanical or osmotic effect of drug injection	33180
@NP	a mechanical or osmotic effect	33180
@NP	drug injection	33214
@NP	the cause of the temporary effect -LRB- Fig. 10C -RRB-	33234
@NP	the cause	33234
@NP	the temporary effect -LRB- Fig. 10C -RRB-	33247
@NP	the temporary effect	33247
@NP	Fig. 10C	33269
@NP	Discussion The rat RST	33281
@NP	Discussion	33281
@NP	The rat RST	33292
@NP	the magnocellular part of the caudal RN	33317
@NP	the magnocellular part	33317
@NP	the caudal RN	33343
@NP	the brain stem	33360
@NP	nearly completely -LRB- 99 % -RRB-	33389
@NP	nearly completely	33389
@NP	99 %	33408
@NP	the dorsolateral aspect	33430
@NP	the spinal cord -LRB- Liu et al. , 1999 ; Kwon et al. , 2002 -RRB-	33457
@NP	the spinal cord	33457
@NP	Liu	33474
@NP	et al. , 1999 ; Kwon et al. , 2002	33478
@NP	et al.	33478
@NP	1999 ; Kwon et al.	33486
@NP	1999	33486
@NP	Kwon et al.	33492
@NP	Kwon	33492
@NP	et al.	33497
@NP	2002	33505
@NP	This lateral position	33512
@NP	the entire RST	33540
@NP	a partial hemisection	33577
@NP	the lateral funiculus and part of the ventral white matter	33609
@NP	the lateral funiculus and part	33609
@NP	the ventral white matter	33643
@NP	the rat	33684
@NP	the rubrospinal system	33693
@NP	the control of skilled limb movement , particularly of the forelimbs	33747
@NP	the control	33747
@NP	skilled limb movement , particularly	33762
@NP	skilled limb movement	33762
@NP	the forelimbs	33801
@NP	Muir	33816
@NP	Whishaw	33825
@NP	2000	33834
@NP	the adult PCHX rat model	33846
@NP	the effect of cellular engrafts	33899
@NP	the effect	33899
@NP	cellular engrafts	33913
@NP	regeneration of rubrospinal axons	33934
@NP	regeneration	33934
@NP	rubrospinal axons	33950
@NP	recovery	33972
@NP	forelimb function	33984
@NP	Liu et al. , 1999 ; Kim et al. , 2001 ; Ruitenberg et al. , 2003	34003
@NP	Liu	34003
@NP	et al. , 1999 ; Kim et al. , 2001 ; Ruitenberg et al. , 2003	34007
@NP	et al. , 1999	34007
@NP	et al.	34007
@NP	1999	34015
@NP	Kim et al. , 2001	34021
@NP	Kim	34021
@NP	et al. , 2001	34025
@NP	et al.	34025
@NP	2001	34033
@NP	Ruitenberg et al. , 2003	34039
@NP	Ruitenberg	34039
@NP	et al. , 2003	34050
@NP	et al.	34050
@NP	2003	34058
@NP	a previous study -LRB- Xiao et al. , 2005 -RRB- and for this study	34069
@NP	a previous study -LRB- Xiao et al. , 2005 -RRB-	34069
@NP	a previous study	34069
@NP	Xiao	34087
@NP	et al. , 2005	34092
@NP	et al.	34092
@NP	2005	34100
@NP	for this study	34110
@NP	we	34126
@NP	the potential	34160
@NP	human olfactory neural progenitors for repair of the injured spinal cord	34177
@NP	human olfactory neural progenitors	34177
@NP	repair of the injured spinal cord	34216
@NP	repair	34216
@NP	the injured spinal cord	34226
@NP	our results	34264
@NP	engraftment of human adult olfactory-derived NSFCs	34332
@NP	engraftment	34332
@NP	human adult olfactory-derived NSFCs	34347
@NP	regeneration and reinnervation of adult rat RST and forelimb functional recovery	34391
@NP	regeneration and reinnervation	34391
@NP	adult rat RST and forelimb functional recovery	34425
@NP	NSFCs	34483
@NP	RST axonal regeneration and reinnervation BDA	34497
@NP	RST axonal regeneration	34497
@NP	reinnervation BDA	34525
@NP	NSFCs	34591
@NP	RST	34605
@NP	axonal regeneration and reestablishment	34609
@NP	synaptic connections with host spinal targets	34652
@NP	synaptic connections	34652
@NP	host spinal targets	34678
@NP	Many regenerated axons	34699
@NP	laminae V -- VII , with terminal --	34739
@NP	laminae V	34739
@NP	VII	34749
@NP	bouton-like structures	34768
@NP	interneurons	34800
@NP	normal RST targets in the spinal cord -LRB- Antal et al. , 1992 -RRB-	34824
@NP	normal RST targets	34824
@NP	the spinal cord -LRB- Antal et al. , 1992 -RRB-	34846
@NP	the spinal cord	34846
@NP	Antal	34863
@NP	et al. , 1992	34869
@NP	et al.	34869
@NP	1992	34877
@NP	segments C6 -- 7	34887
@NP	segments C6	34887
@NP	7	34899
@NP	many regenerating axonal branches and terminals	34902
@NP	many regenerating axonal branches	34902
@NP	terminals	34940
@NP	the ventral horn -LRB- laminae VIII -- IX -RRB-	34972
@NP	the ventral horn	34972
@NP	laminae VIII -- IX	34990
@NP	laminae	34990
@NP	VIII -- IX	34998
@NP	synaptic connections	35015
@NP	motoneuron soma	35041
@NP	The regenerated synapses	35058
@NP	the ultrastructural examination	35109
@NP	BDA-labeled terminals	35157
@NP	synaptic contacts	35184
@NP	the cell bodies or dendrites of ventral horn neurons	35207
@NP	the cell bodies or dendrites	35207
@NP	ventral horn neurons	35239
@NP	C6	35263
@NP	7 segments	35266
@NP	These results	35278
@NP	the previous reports	35312
@NP	some RST terminals	35338
@NP	synapses with distinct motoneurons	35362
@NP	synapses	35362
@NP	distinct motoneurons	35376
@NP	lower cervical segments	35400
@NP	specific , preferential role	35439
@NP	distal forelimb muscle control -LRB- Kuchler et al. , 2002 -RRB-	35470
@NP	distal forelimb muscle control	35470
@NP	Kuchler	35502
@NP	et al. , 2002	35510
@NP	et al.	35510
@NP	2002	35518
@NP	it	35530
@NP	NSFCs	35541
@NP	regeneration	35566
@NP	the formation	35599
@NP	synaptic contacts	35616
@NP	an important issue	35644
@NP	spinal cord repair strategies -LRB- Yakovleff et al. , 1995 -RRB-	35666
@NP	spinal cord repair strategies	35666
@NP	Yakovleff	35697
@NP	et al. , 1995	35707
@NP	et al.	35707
@NP	1995	35715
@NP	our knowledge	35725
@NP	it	35740
@NP	the first report	35746
@NP	RST axons	35768
@NP	synapses	35802
@NP	host spinal targets	35816
@NP	current cell transplantation therapies for spinal cord regeneration	35839
@NP	current cell transplantation therapies	35839
@NP	spinal cord regeneration	35882
@NP	Regeneration and reinnervation by the RST axons	35908
@NP	Regeneration and reinnervation	35908
@NP	the RST axons	35942
@NP	the distance from the graft	35978
@NP	the distance	35978
@NP	the graft	35996
@NP	No regenerated RST axons	36007
@NP	No	36007
@NP	RST axons	36022
@NP	the lower-thoracic or lumbar segments	36045
@NP	the inhibitory environment	36099
@NP	the adult spinal cord	36129
@NP	regeneration following cord injury	36165
@NP	regeneration	36165
@NP	cord injury	36188
@NP	Beattie	36201
@NP	et al. , 1997 ; Geller and Fawcett , 2002	36209
@NP	et al.	36209
@NP	1997 ; Geller and Fawcett	36217
@NP	1997	36217
@NP	Geller and Fawcett	36223
@NP	2002	36243
@NP	This	36250
@NP	the importance of the observed regeneration	36273
@NP	the importance	36273
@NP	the observed regeneration	36291
@NP	the future	36321
@NP	autologous engraftment of NSFCs	36332
@NP	autologous engraftment	36332
@NP	NSFCs	36358
@NP	a useful strategy for patients with upper cervical SCI	36373
@NP	a useful strategy	36373
@NP	patients with upper cervical SCI	36395
@NP	patients	36395
@NP	upper cervical SCI	36409
@NP	only limited regeneration	36438
@NP	several segments of axonal regeneration and reinnervation	36472
@NP	several segments	36472
@NP	axonal regeneration and reinnervation	36492
@NP	patients	36541
@NP	a respirator	36566
@NP	limited mobility	36588
@NP	Tetzlaff , 2001	36615
@NP	Tetzlaff	36615
@NP	2001	36625
@NP	addition	36635
@NP	we	36645
@NP	this reinnervation	36677
@NP	regenerated RST axons	36712
@NP	the plasticity of spared one	36741
@NP	the plasticity	36741
@NP	one	36766
@NP	The interpretations	36771
@NP	the histological analysis	36815
@NP	the right dorsolateral and lateral funiculi	36861
@NP	the right dorsolateral	36861
@NP	lateral funiculi	36888
@NP	the ventral white matter	36935
@NP	the PCHX -LRB- Figs. 1A and 2A , F and H -RRB-	36992
@NP	the PCHX	36992
@NP	Figs. 1A and 2A , F and H	37002
@NP	Figs. 1A	37002
@NP	2A , F and H	37015
@NP	This lesion extent	37029
@NP	the RST -LRB- Liu et al. , 1999 -RRB-	37071
@NP	the RST	37071
@NP	Liu	37080
@NP	et al. , 1999	37084
@NP	et al.	37084
@NP	1999	37092
@NP	evidence	37150
@NP	no BDA-labeled axons	37164
@NP	the lesion site	37209
@NP	all lesion-matrix-only animals in the present study	37228
@NP	all lesion-matrix-only animals	37228
@NP	the present study	37262
@NP	our previous investigation -LRB- Xiao et al. , 2005 -RRB-	37294
@NP	our previous investigation	37294
@NP	Xiao	37322
@NP	et al. , 2005	37327
@NP	et al.	37327
@NP	2005	37335
@NP	the almost complete -LRB- 99 % -RRB- contralateral trajectory of RST	37372
@NP	the almost complete -LRB- 99 % -RRB- contralateral trajectory	37372
@NP	99 %	37393
@NP	RST	37426
@NP	an unambiguous interpretation	37437
@NP	the anatomical	37470
@NP	results	37493
@NP	a unilateral axotomy	37511
@NP	Kwon	37533
@NP	et al. , 2002	37538
@NP	et al.	37538
@NP	2002	37546
@NP	contrast	37556
@NP	other descending pathways	37568
@NP	axons and collateral sprouting	37610
@NP	axons and collateral	37610
@NP	the interpretation -LRB- Waldron and Gwyn , 1969 ; Tracey , 1995 -RRB-	37656
@NP	the interpretation	37656
@NP	Waldron and Gwyn , 1969 ; Tracey , 1995	37676
@NP	Waldron and Gwyn	37676
@NP	1969 ; Tracey	37694
@NP	1969	37694
@NP	Tracey	37700
@NP	1995	37708
@NP	the recovery	37724
@NP	forelimb function	37740
@NP	NSFCs-engrafted animals completely abolished by a second DLF at C2	37761
@NP	NSFCs-engrafted animals	37761
@NP	a second DLF at C2	37809
@NP	a second DLF	37809
@NP	C2	37825
@NP	functional recovery	37855
@NP	due to regeneration of severed neurites	37878
@NP	regeneration of severed	37885
@NP	regeneration	37885
@NP	reorganization of spared axons	37930
@NP	reorganization	37930
@NP	spared axons	37948
@NP	Functional recovery	37962
@NP	RST	37998
@NP	axonal regeneration and reinnervation	38002
@NP	The enhanced function observed in NSFCs-engrafted animals	38040
@NP	The enhanced function	38040
@NP	NSFCs-engrafted animals	38074
@NP	RST axonal regeneration and reinnervation	38114
@NP	RST axonal regeneration	38114
@NP	reinnervation	38142
@NP	Behavioral studies	38157
@NP	the NSFCs-engrafted animals	38194
@NP	use of their forelimb	38250
@NP	use	38250
@NP	their forelimb	38257
@NP	the side of the lesion at 2 weeks	38275
@NP	the side	38275
@NP	the lesion at 2 weeks	38287
@NP	the lesion	38287
@NP	2 weeks	38301
@NP	engraftment	38315
@NP	The improvement	38328
@NP	the 6th week	38360
@NP	it	38379
@NP	observation	38397
@NP	week 12	38418
@NP	The progress of recovery	38427
@NP	The progress	38427
@NP	recovery	38443
@NP	the distance of RST axonal regeneration	38465
@NP	the distance	38465
@NP	RST axonal regeneration	38481
@NP	agreement	38516
@NP	previous data	38531
@NP	the RST axons	38550
@NP	a rate of 1 -- 1.5 mm/day during the first month	38579
@NP	a rate of 1	38579
@NP	a rate	38579
@NP	1	38589
@NP	1.5 mm/day during the first month	38591
@NP	1.5 mm/day	38591
@NP	the first month	38609
@NP	transplantation	38631
@NP	Liu	38648
@NP	et al. , 1999	38652
@NP	et al.	38652
@NP	1999	38660
@NP	it	38667
@NP	about 10 -- 14 days for RST axons	38676
@NP	about 10	38676
@NP	14 days for RST axons	38685
@NP	14 days	38685
@NP	RST axons	38697
@NP	the NSFCs graft	38721
@NP	cervical segments	38747
@NP	3 -- 5 segments proximal to the host --	38771
@NP	3	38771
@NP	5 segments	38773
@NP	the host	38796
@NP	graft interface	38806
@NP	This region of the spinal cord	38823
@NP	This region	38823
@NP	the spinal cord	38838
@NP	the distal joint	38865
@NP	the forelimb -LRB- McKenna et al. , 2000 ; Kuchler et al. , 2002 -RRB-	38885
@NP	the forelimb	38885
@NP	McKenna	38899
@NP	et al. , 2000 ; Kuchler et al. , 2002	38907
@NP	et al.	38907
@NP	2000 ; Kuchler et al.	38915
@NP	2000	38915
@NP	Kuchler et al.	38921
@NP	Kuchler	38921
@NP	et al.	38929
@NP	2002	38937
@NP	the first several weeks after engraftment	38957
@NP	the first several weeks	38957
@NP	engraftment	38987
@NP	RST axonal regeneration and recovery of forelimb function	39015
@NP	RST axonal regeneration	39015
@NP	recovery of forelimb function	39043
@NP	recovery	39043
@NP	forelimb function	39055
@NP	spinal cord injury	39079
@NP	Similar relationships	39099
@NP	studies	39135
@NP	transplanted BDNF engineered fibroblasts	39148
@NP	a cervical cord lesion	39192
@NP	Liu et al. , 1999 ; Jin et al. , 2002 ; Shumsky et al. , 2003	39216
@NP	Liu	39216
@NP	et al. , 1999 ; Jin et al. , 2002 ; Shumsky et al. , 2003	39220
@NP	et al. , 1999	39220
@NP	et al.	39220
@NP	1999	39228
@NP	Jin et al. , 2002	39234
@NP	Jin	39234
@NP	et al. , 2002	39238
@NP	et al.	39238
@NP	2002	39246
@NP	Shumsky et al. , 2003	39252
@NP	Shumsky	39252
@NP	et al. , 2003	39260
@NP	et al.	39260
@NP	2003	39268
@NP	The extent of RST axonal regeneration after a 6-week delay	39275
@NP	The extent	39275
@NP	RST axonal regeneration after a 6-week delay	39289
@NP	RST axonal regeneration	39289
@NP	a 6-week delay	39319
@NP	transplantation	39343
@NP	an acute transplant	39388
@NP	a 4-week delay	39417
@NP	Liu et al. , 1999 ; Jin et al. , 2002 ; Shumsky et al. , 2003	39433
@NP	Liu	39433
@NP	et al. , 1999 ; Jin et al. , 2002 ; Shumsky et al. , 2003	39437
@NP	et al. , 1999	39437
@NP	et al.	39437
@NP	1999	39445
@NP	Jin et al. , 2002	39451
@NP	Jin	39451
@NP	et al. , 2002	39455
@NP	et al.	39455
@NP	2002	39463
@NP	Shumsky et al. , 2003	39469
@NP	Shumsky	39469
@NP	et al. , 2003	39477
@NP	et al.	39477
@NP	2003	39485
@NP	the lesion-matrix-only animals	39503
@NP	independent use	39552
@NP	their impaired forelimb -LRB- Liu et al. , 1999 ; Jin et al. , 2002 -RRB-	39571
@NP	their impaired forelimb	39571
@NP	Liu	39596
@NP	et al. , 1999 ; Jin et al. , 2002	39600
@NP	et al.	39600
@NP	1999 ; Jin et al.	39608
@NP	1999	39608
@NP	Jin et al.	39614
@NP	Jin	39614
@NP	et al.	39618
@NP	2002	39626
@NP	spontaneous vertical exploration	39640
@NP	we	39674
@NP	horizontal rope	39686
@NP	test	39710
@NP	12 weeks	39715
@NP	transplantation	39730
@NP	Results	39747
@NP	NSFCs-engrafted rats	39769
@NP	better performance	39800
@NP	lesion-matrix-only -LRB- data not shown -RRB-	39824
@NP	lesion-matrix-only	39824
@NP	data not shown	39844
@NP	data	39844
@NP	our previous report -LRB- Xiao et al. , 2005 -RRB-	39882
@NP	our previous report	39882
@NP	Xiao	39903
@NP	et al. , 2005	39908
@NP	et al.	39908
@NP	2005	39916
@NP	addition	39926
@NP	we	39936
@NP	the Basso , Beattie , Bresnahan -LRB- BBB -RRB- locomotor rating scale	39954
@NP	Basso , Beattie , Bresnahan -LRB- BBB -RRB-	39958
@NP	Basso , Beattie , Bresnahan	39958
@NP	BBB	39985
@NP	functional recovery of the hind limb 12 weeks	40025
@NP	functional recovery	40025
@NP	the hind limb 12 weeks	40048
@NP	the hind limb	40048
@NP	12 weeks	40062
@NP	transplantation	40077
@NP	BBB scores	40103
@NP	right hind limb -LRB- ipsilateral to the lesion site -RRB-	40117
@NP	right hind limb	40117
@NP	ipsilateral to the lesion site	40134
@NP	ipsilateral	40134
@NP	the lesion site	40149
@NP	the NSFCs-engrafted group	40169
@NP	those	40221
@NP	the lesion-matrix-only -LRB- 16 ± 2.5 vs. 13.5 ± 3.1 , n = 16 , p < 0.05 -RRB-	40230
@NP	the lesion-matrix-only	40230
@NP	16 ± 2.5 vs. 13.5 ± 3.1 , n = 16 , p < 0.05	40254
@NP	16 ± 2.5 vs. 13.5 ± 3.1	40254
@NP	16 ±	40254
@NP	2.5	40257
@NP	13.5 ± 3.1	40265
@NP	n = 16	40275
@NP	n	40275
@NP	16	40277
@NP	p < 0.05	40281
@NP	p <	40281
@NP	p	40281
@NP	0.05	40283
@NP	we	40290
@NP	this behavioral improvement	40311
@NP	RST axonal regeneration	40342
@NP	the Results section -LRB- Fig. 3 -RRB-	40388
@NP	the Results section	40388
@NP	Fig. 3	40409
@NP	most of the regenerated RST axons	40418
@NP	most	40418
@NP	the regenerated RST axons	40426
@NP	the distal cervical segments and a few	40468
@NP	the distal cervical segments	40468
@NP	a few	40501
@NP	the mid-thoracic segments	40515
@NP	no BDA-labeled axon	40546
@NP	the L1 -- S5 segments in NSFCs-engrafted rats	40582
@NP	the L1	40582
@NP	S5 segments in NSFCs-engrafted rats	40589
@NP	S5 segments	40589
@NP	NSFCs-engrafted rats	40604
@NP	our opinion	40629
@NP	one	40642
@NP	the functional recovery	40682
@NP	cellular transplantation	40712
@NP	clear and unambiguous evidence	40745
@NP	the conclusion of axonal regeneration	40785
@NP	the conclusion	40785
@NP	axonal regeneration	40803
@NP	Partial recovery of hind limb function in PCHX rat model	40824
@NP	Partial recovery	40824
@NP	hind limb function in PCHX rat model	40844
@NP	hind limb function	40844
@NP	PCHX rat model	40866
@NP	the collateral branches of other intact descending tracts in the distal segments	40917
@NP	the collateral branches	40917
@NP	other intact descending tracts in the distal segments	40944
@NP	other intact descending tracts	40944
@NP	the distal segments	40978
@NP	Functional recovery	40999
@NP	irreversible and reversible lesions of regenerated RST	41036
@NP	irreversible and reversible lesions	41036
@NP	regenerated RST	41075
@NP	Functional recovery	41091
@NP	RST axonal regeneration and reinnervation	41127
@NP	RST axonal regeneration	41127
@NP	reinnervation	41155
@NP	occurrences of forelimb dysfunction	41197
@NP	occurrences	41197
@NP	forelimb dysfunction	41212
@NP	irreversible and reversible lesions of RST	41239
@NP	irreversible and reversible lesions	41239
@NP	RST	41278
@NP	Recovery of forelimb usage	41283
@NP	Recovery	41283
@NP	forelimb usage	41295
@NP	an irreversible lesion	41335
@NP	the regenerated RST axons following the right DLF at the C2 level	41361
@NP	the regenerated RST axons	41361
@NP	the right DLF at the C2 level	41397
@NP	the right DLF	41397
@NP	the C2 level	41414
@NP	This procedure	41428
@NP	the regenerated RST axons and results in forelimb dysfunction	41461
@NP	the regenerated RST axons and results	41461
@NP	forelimb dysfunction	41502
@NP	regenerated RST axons	41530
@NP	recovery of forelimb posture and motor function	41575
@NP	recovery	41575
@NP	forelimb posture and motor function	41587
@NP	These results	41624
@NP	those	41653
@NP	previous studies	41672
@NP	other engraftment procedures -LRB- Liu et al. , 1999 ; Jin et al. , 2002 -RRB-	41694
@NP	other engraftment procedures	41694
@NP	Liu	41724
@NP	et al. , 1999 ; Jin et al. , 2002	41728
@NP	et al.	41728
@NP	1999 ; Jin et al.	41736
@NP	1999	41736
@NP	Jin et al.	41742
@NP	Jin	41742
@NP	et al.	41746
@NP	2002	41754
@NP	the irreversible surgical lesion	41773
@NP	reversible blockade of RN neurons by muscimol	41807
@NP	reversible blockade	41807
@NP	RN neurons by muscimol	41830
@NP	RN neurons	41830
@NP	muscimol	41844
@NP	more direct evidence	41862
@NP	the regenerated RST axons	41888
@NP	the recovery of forelimb function	41928
@NP	the recovery	41928
@NP	forelimb function	41944
@NP	Muscimol	41963
@NP	gammaaminobutyric acid -LRB- GABA -RRB- agonist	41993
@NP	inactivation experiments -LRB- Martin and Ghez , 1999 -RRB-	42035
@NP	inactivation experiments	42035
@NP	Martin and Ghez	42061
@NP	1999	42078
@NP	It	42085
@NP	cells bodies where the GABA receptor is located	42110
@NP	cells bodies	42110
@NP	the GABA receptor	42129
@NP	axons -LRB- Martin and Ghez , 1999 -RRB-	42167
@NP	axons	42167
@NP	Martin and Ghez	42174
@NP	1999	42191
@NP	Previous studies	42198
@NP	the distribution of GABA receptors	42233
@NP	the distribution	42233
@NP	GABA receptors	42253
@NP	the RN -LRB- Hironaka et al. , 1990 -RRB-	42271
@NP	the RN	42271
@NP	Hironaka	42279
@NP	et al. , 1990	42288
@NP	et al.	42288
@NP	1990	42296
@NP	Injection of muscimol into the RN	42303
@NP	Injection	42303
@NP	muscimol into the RN	42316
@NP	muscimol	42316
@NP	the RN	42330
@NP	reversible impairment	42363
@NP	an elbow tracking task of cats for several days -LRB- Martin et al. , 1993 -RRB-	42388
@NP	an elbow tracking task	42388
@NP	cats for several days -LRB- Martin et al. , 1993 -RRB-	42414
@NP	cats	42414
@NP	several days -LRB- Martin et al. , 1993 -RRB-	42423
@NP	several days	42423
@NP	Martin	42437
@NP	et al. , 1993	42444
@NP	et al.	42444
@NP	1993	42452
@NP	Injection of muscimol into the magnocellular portion of the RN	42459
@NP	Injection	42459
@NP	muscimol into the magnocellular portion of the RN	42472
@NP	muscimol	42472
@NP	the magnocellular portion of the RN	42486
@NP	the magnocellular portion	42486
@NP	the RN	42515
@NP	the comparison of posture and motor function of the contralateral forelimb	42527
@NP	the comparison	42527
@NP	posture and motor function of the contralateral forelimb	42545
@NP	posture and motor function	42545
@NP	the contralateral forelimb	42575
@NP	recovery possible	42627
@NP	Significant proximal and distal forelimb dysfunction relating to extension	42646
@NP	Significant proximal and distal forelimb dysfunction	42646
@NP	distal forelimb	42671
@NP	extension	42711
@NP	18	42735
@NP	24 h after injection	42738
@NP	24 h	42738
@NP	injection	42749
@NP	it	42796
@NP	48 h.	42824
@NP	Similar	42830
@NP	the irreversible lesion by the rostral DLF , the injection of muscimol	42841
@NP	the irreversible lesion	42841
@NP	the rostral DLF , the injection of muscimol	42868
@NP	the rostral DLF	42868
@NP	the injection of muscimol	42885
@NP	the injection	42885
@NP	muscimol	42902
@NP	no right forelimb usage and limited use	42923
@NP	no right forelimb usage	42923
@NP	limited use	42951
@NP	forelimbs indicating the pharmacological blockade	42971
@NP	forelimbs	42971
@NP	the pharmacological blockade	42992
@NP	RST	43049
@NP	These results	43072
@NP	repeated injections of muscimol	43114
@NP	repeated injections	43114
@NP	muscimol	43137
@NP	muscimol reactions	43153
@NP	pharmacological inactivation	43203
@NP	an effective tool in assessing functional recovery after spinal cord injury	43239
@NP	an effective tool	43239
@NP	functional recovery	43270
@NP	spinal cord injury	43296
@NP	We	43316
@NP	this	43327
@NP	the first time	43335
@NP	pharmacologic inactivation	43355
@NP	recovery of forelimb function and regeneration of RST axons	43407
@NP	recovery	43407
@NP	forelimb function and regeneration	43419
@NP	RST axons	43457
@NP	conclusion	43471
@NP	the present studies	43483
@NP	neural progenitors from adult human ONe progenitors	43535
@NP	neural progenitors	43535
@NP	adult human ONe progenitors	43559
@NP	RST axonal regeneration and reinnervation	43599
@NP	RST axonal regeneration	43599
@NP	reinnervation	43627
@NP	functional recovery	43653
@NP	the acute SCI of rats	43683
@NP	the acute SCI	43683
@NP	rats	43700
@NP	NSFCs harvested from ONe	43706
@NP	NSFCs	43706
@NP	ONe	43727
@NP	a suitable source	43739
@NP	adult neural progenitor cells	43760
@NP	minimally invasive surgery	43817
@NP	the progenitor nature of these NSFCs	43852
@NP	the progenitor nature	43852
@NP	these NSFCs	43877
@NP	they	43890
@NP	either oligodendrocytes or neurons	43920
@NP	Marshall et al. , 2006	43956
@NP	Marshall	43956
@NP	et al.	43965
@NP	2006	43973
@NP	Adult human ONe progenitors	43980
@NP	a unique therapeutic potential	44017
@NP	use	44052
@NP	autologous grafting or transplantation	44059
@NP	SCI and other neurodegenerative disorders	44117
@NP	SCI	44117
@NP	other neurodegenerative disorders	44125
@VP	ablated the RST	504
@VP	tracing with biotinylated dextran amine -LRB- BDA -RRB-	680
@VP	biotinylated dextran amine -LRB- BDA -RRB-	693
@VP	blocking RST neuronal activity reversibly	1235
@VP	to regenerate in the adult central nervous system	1466
@VP	regenerate in the adult central nervous system	1469
@VP	to promote regeneration in several neurodegenerative or neurotrauma models	1785
@VP	promote regeneration in several neurodegenerative or neurotrauma models	1788
@VP	have promoted injured axonal regeneration and animals ' functional recovery	2306
@VP	promoted injured axonal regeneration and animals ' functional recovery	2311
@VP	can be used to treat patients with SCI -LRB- Kwon and Tetzlaff , 2001 -RRB-	2421
@VP	be used to treat patients with SCI -LRB- Kwon and Tetzlaff , 2001 -RRB-	2425
@VP	used to treat patients with SCI -LRB- Kwon and Tetzlaff , 2001 -RRB-	2428
@VP	to treat patients with SCI -LRB- Kwon and Tetzlaff , 2001 -RRB-	2433
@VP	treat patients with SCI -LRB- Kwon and Tetzlaff , 2001 -RRB-	2436
@VP	is needed -LRB- Feron et al. , 1998 ; Roisen et al. , 2001 -RRB-	2858
@VP	needed -LRB- Feron et al. , 1998 ; Roisen et al. , 2001 -RRB-	2861
@VP	is unique compared to other regions of the CNS	2947
@VP	undergoing nasal sinus surgery -LRB- Winstead et al. , 2005 -RRB-	3517
@VP	indicated by a remarkable level of proliferation and viability	3670
@VP	engrafted NSFCs	4256
@VP	survive	4272
@VP	migrate	4281
@VP	axotomized rubrospinal tract -LRB- RST -RRB- neurons from retrograde atrophy	4336
@VP	leads to functional recovery -LRB- Xiao et al. , 2005 -RRB-	4451
@VP	has been described previously	5010
@VP	been described previously	5014
@VP	described previously	5019
@VP	using the LERS -- EGFP vector -LRB- Kinsella and Nolan , 1996 -RRB-	5192
@VP	was readily detected in > 60 % of the cells	5276
@VP	detected in > 60 % of the cells	5288
@VP	were cultured for up to 40 passages	5331
@VP	cultured for up to 40 passages	5336
@VP	were frozen in liquid nitrogen for transplantation	5395
@VP	frozen in liquid nitrogen for transplantation	5400
@VP	obtained from frozen stock	5502
@VP	rapidly thawed	5530
@VP	were weaned from FBS 10 % , 5 % to 2.5 % every 2 days in vitro	5640
@VP	weaned from FBS 10 % , 5 % to 2.5 % every 2 days in vitro	5645
@VP	then maintained in MEM	5700
@VP	detached from the culture surface	5780
@VP	pelleted by lowspeed centrifugation	5815
@VP	maintained at 4 °C	5974
@VP	described	6154
@VP	were examined for their forelimb posture	6376
@VP	examined for their forelimb posture	6381
@VP	was used to obtain the baseline data prior to surgery	6430
@VP	used to obtain the baseline data prior to surgery	6434
@VP	to obtain the baseline data prior to surgery	6439
@VP	obtain the baseline data prior to surgery	6442
@VP	to establish baseline data for anterograde tracing from the RN	6557
@VP	establish baseline data for anterograde tracing from the RN	6560
@VP	tracing from the RN	6600
@VP	suspended in Matrigel ® matrix	6755
@VP	were randomly divided into three subgroups	6972
@VP	divided into three subgroups	6986
@VP	received a BDA injection into the left RN	7053
@VP	survived an additional 2 weeks	7099
@VP	killed for immunohistochemistry and immunoelectron microscopic analysis	7145
@VP	followed by behavioral testing weekly for 4 additional weeks before sacrifice	7328
@VP	to reversibly block RN neuronal function	7505
@VP	reversibly block RN neuronal function	7508
@VP	received an additional injection of muscimol or saline	7688
@VP	tested	7744
@VP	then killed for histological study	7756
@VP	described	7963
@VP	were approved by the Animal Care and Use Committee of Nanjing Medical University	8019
@VP	approved by the Animal Care and Use Committee of Nanjing Medical University	8024
@VP	was performed as previously described	8258
@VP	performed as previously described	8262
@VP	described	8286
@VP	was exposed by dorsal laminectomy of the C3 and C4 vertebrae	8470
@VP	exposed by dorsal laminectomy of the C3 and C4 vertebrae	8474
@VP	damaged the right dorsal and ventral columns and gray matter	8766
@VP	remained intact	8855
@VP	was placed in the cavity to stop the bleeding and removed after 5 min	8892
@VP	placed in the cavity to stop the bleeding and removed after 5 min	8896
@VP	placed in the cavity to stop the bleeding	8896
@VP	to stop the bleeding	8917
@VP	stop the bleeding	8920
@VP	removed after 5 min	8942
@VP	was drawn into a 25 μl	9104
@VP	drawn into a 25 μl	9108
@VP	attached to a glass pipette	9144
@VP	to allow the Matrigel ® matrix to partly solidify	9239
@VP	allow the Matrigel ® matrix to partly solidify	9242
@VP	to partly solidify	9269
@VP	partly solidify	9272
@VP	was slowly injected into the lesion site	9306
@VP	injected into the lesion site	9317
@VP	were closed with sutures while the skin was closed with wound clips	9375
@VP	closed with sutures while the skin was closed with wound clips	9380
@VP	was closed with wound clips	9415
@VP	closed with wound clips	9419
@VP	subjected to a second laminectomy at the level of C2	9483
@VP	using the same procedure as described above	9592
@VP	described above	9620
@VP	were anesthetized as described above and positioned in a stereotaxic apparatus	9676
@VP	described above	9697
@VP	positioned in a stereotaxic apparatus	9717
@VP	coordinates described previously -LRB- Mori et al. , 1997 -RRB-	9773
@VP	described previously -LRB- Mori et al. , 1997 -RRB-	9785
@VP	was orientated as the injection site	9868
@VP	orientated as the injection site	9872
@VP	attached to a 1-μl Hamilton syringe	10172
@VP	left in place for an additional 20 min and gradually withdrawn after 2 -- 3 min	10224
@VP	left in place for an additional 20 min	10224
@VP	gradually withdrawn after 2 -- 3 min	10267
@VP	to study reinnervation of the forelimb	10411
@VP	study reinnervation of the forelimb	10414
@VP	was observed when the animals recovered from anesthesia and began to move about	10474
@VP	observed when the animals recovered from anesthesia and began to move about	10478
@VP	recovered from anesthesia and began to move about	10504
@VP	recovered from anesthesia	10504
@VP	began to move about	10534
@VP	to move about	10540
@VP	move about	10543
@VP	was used to assess damage to the RST following the PCHX	10590
@VP	used to assess damage to the RST following the PCHX	10594
@VP	to assess damage to the RST following the PCHX	10599
@VP	assess damage to the RST following the PCHX	10602
@VP	is a highly sensitive test for asymmetries of limb function	10688
@VP	influence the asymmetry score -LRB- Liu et al. , 1999 ; Jin et al. , 2002 -RRB-	10779
@VP	were given one preoperative test and were examined weekly after engraftment	10856
@VP	were given one preoperative test	10856
@VP	given one preoperative test	10861
@VP	were examined weekly after engraftment	10893
@VP	examined weekly after engraftment	10898
@VP	were completed in a double-blind study	10966
@VP	completed in a double-blind study	10971
@VP	was described previously -LRB- Xiao et al. , 2005 -RRB-	11045
@VP	described previously -LRB- Xiao et al. , 2005 -RRB-	11049
@VP	were placed in a clear glass cylinder 20 cm in diameter and 30 cm high for 5 min	11106
@VP	placed in a clear glass cylinder 20 cm in diameter and 30 cm high for 5 min	11111
@VP	contacting the wall of the cylinder during vertical posturing	11268
@VP	perfused through the heart with 200 ml of 0.01 M PBS , pH 7.4	11537
@VP	dissected out	11880
@VP	followed by cytoprotection in PB containing 30 % sucrose for 1	11946
@VP	containing 30 % sucrose for 1	11979
@VP	embedded in OCT compound	12054
@VP	serially cut at 20 μm by a cryostat and mounted on gelatin-coated slides	12083
@VP	serially cut at 20 μm by a cryostat	12083
@VP	mounted on gelatin-coated slides	12123
@VP	collected in 0.1 M PB -LRB- pH 7.4 -RRB-	12322
@VP	were as described previously -LRB- Xiao et al. , 2005 -RRB-	12446
@VP	described previously -LRB- Xiao et al. , 2005 -RRB-	12454
@VP	washing	13045
@VP	were applied	13254
@VP	applied	13259
@VP	was visualized using hydrogen peroxidase and diaminobenzidine as chromogen	13566
@VP	visualized using hydrogen peroxidase and diaminobenzidine as chromogen	13570
@VP	using hydrogen peroxidase and diaminobenzidine as chromogen	13581
@VP	insured the specificity of the reaction	13686
@VP	tracing	13812
@VP	were stained with biotin -- FITC -LRB- Sigma , St.	13825
@VP	stained with biotin -- FITC -LRB- Sigma , St.	13830
@VP	using previous procedures -LRB- Liu et al. , 1999 ; Xiao et al. , 2005 -RRB-	13883
@VP	incubated overnight at 4 °C with rabbit	14125
@VP	rinsed three times for 10 min each with PBS	14236
@VP	were rinsed and mounted	14448
@VP	rinsed and mounted	14453
@VP	controls demonstrated the specificity of each reaction	14512
@VP	demonstrated the specificity of each reaction	14521
@VP	stained with an ABC elite kit -LRB- Vector -RRB-	14680
@VP	visualized with nickelintensified diaminobenzidine	14723
@VP	were visualized with nickel-intensified diaminobenzidine -LRB- Sigma , St.	15125
@VP	visualized with nickel-intensified diaminobenzidine -LRB- Sigma , St.	15130
@VP	mounted on subbed slides for light microscopic examination	15271
@VP	subbed slides for light microscopic examination	15282
@VP	prepared for electron microscopy as described below	15334
@VP	described below	15370
@VP	Selected sections	15387
@VP	were post-fixed in 2 %	15405
@VP	dehydrated in an ascending alcohol series , and embedded in durcupan resin	15462
@VP	dehydrated in an ascending alcohol series	15462
@VP	embedded in durcupan resin	15509
@VP	Selected areas of the ventral horn	15537
@VP	were dissected out	15572
@VP	dissected out	15577
@VP	were cut	15629
@VP	cut	15634
@VP	formvarcoated nickel slot grids and stained with uranyl acetate for 30 min	15679
@VP	formvarcoated nickel slot grids	15679
@VP	stained with uranyl acetate for 30 min	15715
@VP	were examined using a CM12 Philips electron microscope	15771
@VP	examined using a CM12 Philips electron microscope	15776
@VP	using a CM12 Philips electron microscope	15785
@VP	using a confocal microscopy	16078
@VP	labeled axons in the dorsolateral or lateral funiculi	16112
@VP	were counted	16166
@VP	counted	16171
@VP	were included	16231
@VP	included	16236
@VP	obtained from the histological assessments and behavioral tests	16251
@VP	using either Student 's t-test or one-way ANOVA	16379
@VP	were presented as mean ± standard deviation -LRB- SD -RRB-	16449
@VP	presented as mean ± standard deviation -LRB- SD -RRB-	16454
@VP	were prepared using Microsoft Excel software	16508
@VP	prepared using Microsoft Excel software	16513
@VP	using Microsoft Excel software	16522
@VP	survived in the lesion cavity	16812
@VP	dashed lines in A , C and D	16928
@VP	being detected in the graft -LRB- arrows in D -RRB-	17067
@VP	detected in the graft -LRB- arrows in D -RRB-	17073
@VP	were present in the graft -LRB- arrows in B and C -RRB-	17124
@VP	exhibited immunoreactivity for BDNF -LRB- arrowheads in yellow ; C -RRB-	17182
@VP	is referred to the web version of this article	17542
@VP	referred to the web version of this article	17545
@VP	showing lesion extent , host	17650
@VP	were stained with toluidine blue to	17837
@VP	stained with toluidine blue to	17842
@VP	dashed lines in A , C and D	17904
@VP	engrafted cells	17993
@VP	intermingled with numerous axons -LRB- arrowheads in E -RRB-	18089
@VP	to show host immune response	18246
@VP	show host immune response	18249
@VP	Activated astrocytes -LRB- F and G -RRB- , macrophages	18276
@VP	accumulated at the graft -- host interface	18354
@VP	were in the graft	18403
@VP	caudal to the graft site	18488
@VP	was similar to normal at the lower-cervical segments -LRB- p > 0.05 -RRB-	18549
@VP	were observed at the lower-thoracic and lumbar segments	18709
@VP	observed at the lower-thoracic and lumbar segments	18714
@VP	decreased with the distance from the lesion -- graft site	18798
@VP	illustrating BDA-labeled RST axons	18961
@VP	were found in the dorsolateral funiculus	19159
@VP	found in the dorsolateral funiculus	19164
@VP	were present in lamina V -- VII of the gray matter -LRB- B -RRB-	19217
@VP	sent collaterals into the gray matter -LRB- arrows in F -RRB-	19686
@VP	outlined area , high magnification is shown in A	19829
@VP	is shown in A	19863
@VP	shown in A	19866
@VP	suggests that they were not completely in a rostrocaudal alignment -LRB- H -RRB-	20064
@VP	were not completely in a rostrocaudal alignment -LRB- H -RRB-	20083
@VP	were scattered throughout the ventral horn	20349
@VP	scattered throughout the ventral horn	20354
@VP	resemble terminal boutons	20491
@VP	surrounded motoneuron soma -LRB- stars in E and F -RRB-	20524
@VP	were synapsinpositive	20576
@VP	is referred to the web version of this article	20791
@VP	referred to the web version of this article	20794
@VP	indicating an incomplete myelin repair	21419
@VP	-LRB- A and D -RRB- 1 week after engraftment	21955
@VP	-LRB- B and E -RRB- 6 weeks after engraftment	22148
@VP	were further flexed in the same lesion-matrix-only animal -LRB- B -RRB-	22217
@VP	flexed in the same lesion-matrix-only animal -LRB- B -RRB-	22230
@VP	were fully extended in the same lesion plus engrafted animal -LRB- E -RRB-	22295
@VP	extended in the same lesion plus engrafted animal -LRB- E -RRB-	22306
@VP	plus engrafted animal -LRB- E -RRB-	22334
@VP	resulting in forelimb flexion in the NSFCsengrafted animal -LRB- F -RRB-	22557
@VP	using right	22853
@VP	left forepaws independently or both forepaws simultaneously	22868
@VP	exhibited use of the right forelimb during the first 2 weeks after engraftment	22943
@VP	was noted in the right forelimb of lesion-matrix-only animals	23049
@VP	noted in the right forelimb of lesion-matrix-only animals	23053
@VP	was noted in the engrafted animals from week 3	23191
@VP	noted in the engrafted animals from week 3	23195
@VP	engrafted animals from week 3	23208
@VP	remained constant to week 12	23313
@VP	demonstrating the forelimb use 12 weeks after engraftment	23364
@VP	strongly flexed	23480
@VP	rarely used during spontaneous vertical exploration -LRB- arrow -RRB-	23500
@VP	to explore the cylinder	23710
@VP	explore the cylinder	23713
@VP	demonstrating the recovered right forelimb	23735
@VP	was abolished by the drug-induced blockade	23956
@VP	abolished by the drug-induced blockade	23960
@VP	regained the use of the right paw	24015
@VP	had passed 48 h later -LRB- arrow -RRB-	24107
@VP	passed 48 h later -LRB- arrow -RRB-	24111
@VP	was examined by irreversible and reversible lesions 12 weeks after engraftment	24254
@VP	examined by irreversible and reversible lesions 12 weeks after engraftment	24258
@VP	had little effect on the lesion-matrix-only animals -LRB- n = 6 , p > 0.05 -RRB-	24366
@VP	evaluated -LRB- n = 6 , p < 0.01 -RRB-	24567
@VP	affect forelimb usage of NSFCs-engrafted animals -LRB- n = 6 , p > 0.05 -RRB-	24646
@VP	disappeared after a 48-h recovery period	24897
@VP	containing the RST	25304
@VP	Engrafted	25420
@VP	completely filled the lesion cavity	25436
@VP	remained immunoreactive for BDNF -LRB- Fig. 1C -RRB-	25631
@VP	engrafted NSFCs	25687
@VP	To characterize the host immune response	25910
@VP	characterize the host immune response	25913
@VP	to identify activated macrophages and microglia	26072
@VP	identify activated macrophages and microglia	26075
@VP	few in the graft	26270
@VP	engrafted NSFCs	26471
@VP	axotomized RST axonal regeneration	26495
@VP	was similar to the previous data -LRB- Xiao et al. , 2005 -RRB-	26663
@VP	to avoid the repeated description	26726
@VP	avoid the repeated description	26729
@VP	regenerated into segments	26848
@VP	caudal to the lesion -- graft site	26874
@VP	tracing NSFCs-engrafted animals	27074
@VP	were found caudal to the lesion site	27125
@VP	found caudal to the lesion site	27130
@VP	decreased in number the farther caudal to the graft -LRB- Fig. 3 -RRB-	27337
@VP	the farther caudal to the graft	27357
@VP	was similar to control RST axons	27481
@VP	to control RST axons	27493
@VP	control RST axons	27496
@VP	were seen in comparison to the controls -LRB- Fig. 4 -RRB-	27561
@VP	seen in comparison to the controls -LRB- Fig. 4 -RRB-	27566
@VP	to reestablish synaptic connections with their spinal targets	27662
@VP	reestablish synaptic connections with their spinal targets	27665
@VP	was observed in segments caudal to the lesion -- graft site	27802
@VP	observed in segments caudal to the lesion -- graft site	27806
@VP	caudal to the lesion	27827
@VP	to laminae V -- VII of the ipsilateral gray matter -LRB- Figs. 4C and D -RRB-	27960
@VP	laminae V -- VII of the ipsilateral gray matter -LRB- Figs. 4C and D -RRB-	27963
@VP	surrounded the somata of motoneurons	28360
@VP	formed presynaptic boutons -LRB- Figs. 5E -- F -RRB-	28401
@VP	were found	28501
@VP	found	28506
@VP	were still evident in the dorsolateral funiculus -LRB- Figs. 4G and H -RRB-	28622
@VP	engrafted rats -LRB- Figs. 6A and B -RRB-	29020
@VP	was characterized by the loose and thin myelin sheaths -LRB- Fig. 6C -RRB-	29167
@VP	characterized by the loose and thin myelin sheaths -LRB- Fig. 6C -RRB-	29171
@VP	used for electron microscopic examination	29338
@VP	found in the ventral horn of C6 segment in lesion-matrix-only animals	29433
@VP	replaced with astrocytes	29504
@VP	Engrafted NSFCs promote functional recovery Forelimb positioning	29587
@VP	promote functional recovery Forelimb positioning	29603
@VP	positioning	29640
@VP	was observed at different times after engraftment	29652
@VP	observed at different times after engraftment	29656
@VP	was seen in some NSFCs-engrafted animals early as 2 weeks after engraftment	30044
@VP	seen in some NSFCs-engrafted animals early as 2 weeks after engraftment	30048
@VP	evaluated	30259
@VP	engrafted animals	30286
@VP	demonstrated corresponding functional recovery	30465
@VP	using both forelimbs to explore the wall -LRB- Fig. 8 -RRB-	30647
@VP	to explore the wall -LRB- Fig. 8 -RRB-	30668
@VP	explore the wall -LRB- Fig. 8 -RRB-	30671
@VP	indicating limited functional recovery -LRB- Fig. 8B -RRB-	30940
@VP	was noted in the NSFCs-engrafted animals -LRB- Fig. 8B -RRB-	31049
@VP	noted in the NSFCs-engrafted animals -LRB- Fig. 8B -RRB-	31053
@VP	was 80 % , which closely approximated the preoperative level -LRB- 90 % -RRB-	31192
@VP	approximated the preoperative level -LRB- 90 % -RRB-	31215
@VP	maintained through the remaining observation period -LRB- Figs. 8B and 9B -RRB-	31285
@VP	were irreversibly injured by a second DLF to the right C2 segment	31654
@VP	injured by a second DLF to the right C2 segment	31672
@VP	engrafted animals , the restored extension of the forepaw and recovered forelimb	31945
@VP	engrafted animals , the restored extension of the forepaw	31945
@VP	recovered forelimb	32006
@VP	was apparent as soon as the animals awoke and began to ambulate	32382
@VP	awoke and began to ambulate	32418
@VP	awoke	32418
@VP	began to ambulate	32428
@VP	to ambulate	32434
@VP	ambulate	32437
@VP	persisted for 18 -- 24 h -LRB- Fig. 9C -RRB-	32464
@VP	returned -LRB- Fig. 9D -RRB-	32531
@VP	engrafted animals receiving saline alone or muscimol	32578
@VP	receiving saline alone or muscimol	32596
@VP	obtained when the animals received an additional injection -LRB- p > 0.05 -RRB-	32947
@VP	received an additional injection -LRB- p > 0.05 -RRB-	32973
@VP	received saline injections to the RN	33048
@VP	was the cause of the temporary effect -LRB- Fig. 10C -RRB-	33230
@VP	emerges from the magnocellular part of the caudal RN in the brain stem	33304
@VP	crosses over nearly completely -LRB- 99 % -RRB-	33376
@VP	are ablated	33668
@VP	ablated	33672
@VP	improve RST axonal regeneration and reinnervation BDA anterograde tracing	34489
@VP	tracing	34555
@VP	demonstrated that engrafted NSFCs improve RST	34563
@VP	engrafted NSFCs	34581
@VP	improve RST	34597
@VP	are normal RST targets in the spinal cord -LRB- Antal et al. , 1992 -RRB-	34820
@VP	forming synaptic connections with motoneuron soma	35007
@VP	appears NSFCs	35533
@VP	influence regeneration	35556
@VP	decreased the greater the distance from the graft	35956
@VP	regenerated RST axons	36010
@VP	hinders regeneration following cord injury	36157
@VP	does not diminish the importance of the observed regeneration	36255
@VP	diminish the importance of the observed regeneration	36264
@VP	could be a useful strategy for patients with upper cervical SCI	36364
@VP	be a useful strategy for patients with upper cervical SCI	36370
@VP	occurs	36464
@VP	breathe without a respirator	36550
@VP	gain limited mobility -LRB- Kwon and Tetzlaff , 2001 -RRB-	36583
@VP	is sustained by regenerated RST axons not by the plasticity of spared one	36696
@VP	sustained by regenerated RST axons not by the plasticity of spared one	36699
@VP	spared one	36759
@VP	are as follow	36791
@VP	follow	36798
@VP	were completely disrupted	36905
@VP	completely disrupted	36910
@VP	was partially ablated following the PCHX -LRB- Figs. 1A and 2A , F and H -RRB-	36960
@VP	mentioned above	37355
@VP	sprouting	37631
@VP	completely abolished by a second DLF at C2	37785
@VP	severed	37901
@VP	observed in NSFCs-engrafted animals	38062
@VP	correlates with RST axonal regeneration and reinnervation	38098
@VP	remained until observation ended at week 12	38382
@VP	ended at week 12	38409
@VP	conformed to the distance of RST axonal regeneration	38452
@VP	go through the NSFCs graft	38710
@VP	reach cervical segments about 3 -- 5 segments proximal to the host --	38741
@VP	following an acute transplant	39378
@VP	did horizontal rope walking test 12 weeks after transplantation	39682
@VP	walking test 12 weeks after transplantation	39702
@VP	not shown	39849
@VP	was similar to our previous report -LRB- Xiao et al. , 2005 -RRB-	39867
@VP	to evaluate functional recovery of the hind limb 12 weeks after transplantation	40013
@VP	evaluate functional recovery of the hind limb 12 weeks after transplantation	40016
@VP	did not attribute this behavioral improvement to RST axonal regeneration	40293
@VP	attribute this behavioral improvement to RST axonal regeneration	40301
@VP	shown in the Results section -LRB- Fig. 3 -RRB-	40379
@VP	were present at the distal cervical segments and a few	40452
@VP	reached the mid-thoracic segments	40507
@VP	was detected at the L1 -- S5 segments in NSFCs-engrafted rats	40566
@VP	detected at the L1 -- S5 segments in NSFCs-engrafted rats	40570
@VP	assessing the functional recovery after cellular transplantation	40672
@VP	supports the conclusion of axonal regeneration	40776
@VP	was abolished by irreversible and reversible lesions of regenerated RST	41019
@VP	abolished by irreversible and reversible lesions of regenerated RST	41023
@VP	severs the regenerated RST axons and results in forelimb dysfunction	41454
@VP	contribute to recovery of forelimb posture and motor function	41561
@VP	contribute to the recovery of forelimb function	41914
@VP	is located	42147
@VP	relating to extension	42699
@VP	persisted for 18 -- 24 h after injection	42721
@VP	gradually disappeared until it was completely absent by 48 h.	42768
@VP	was completely absent by 48 h.	42799
@VP	indicating the pharmacological blockade	42981
@VP	was able to totally depress RST	43021
@VP	to totally depress RST	43030
@VP	totally depress RST	43033
@VP	were reproducible following repeated injections of muscimol	43086
@VP	are reversible and repeatable	43172
@VP	be an effective tool in assessing functional recovery after spinal cord injury	43236
@VP	assessing functional recovery after spinal cord injury	43260
@VP	been correlated with recovery of forelimb function and regeneration of RST axons	43386
@VP	correlated with recovery of forelimb function and regeneration of RST axons	43391
@VP	can promote RST axonal regeneration and reinnervation	43587
@VP	promote RST axonal regeneration and reinnervation	43591
@VP	enhance functional recovery following the acute SCI of rats	43645
@VP	harvested from ONe	43712
@VP	can be obtained with minimally invasive surgery	43796
@VP	be obtained with minimally invasive surgery	43800
@VP	obtained with minimally invasive surgery	43803
@VP	aimed at repairing SCI and other neurodegenerative disorders	44098
@VP	repairing SCI and other neurodegenerative disorders	44107
